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ABSTRACT 
 
 The purpose of this dissertation study was to identify previvors’ sources of 
uncertainty and strategies for managing uncertainty and understand how previvors’ 
uncertainty influence what type of preventative health decisions they make and how 
those decisions affect their subsequent sense of uncertainty.  A previvor is an individual 
who is highly predisposed to breast and ovarian cancer due to a genetic mutation called 
BRCA1/2.  Previvors have a 44 to 87 percent risk of developing cancer during their 
lifetime.  Consequently, previvors live in a constant state of uncertainty—wondering not 
if they might get cancer but when—and must make certain preventative health decisions 
to reduce their cancer risk.  
 To understand previvors’ health experiences, thirty-four, semi-structured 
interviews were conducted with female previvors.  Participants were recruited through 
Facing Our Risk of Cancer Empowered’s (FORCE) social media pages.  Interviews were 
recorded and transcribed.  The constant comparison method was employed to code the 
interview transcriptions, and the interview transcripts’ themes served as the units of 
analysis.  
First, analysis revealed two main uncertainty sources for previvors—medical 
uncertainty and familial uncertainty.  Medical uncertainty types include the unknown 
future, peaks and valleys associated with medical consultations, and personal cancer 
scares.  Familial uncertainty encompasses traumatic family cancer experiences and being 
a mother and being present in children’s lives.  Second, four uncertainty management 
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strategies—seeking clinicians as an informational source, seeking clinicians as a partner 
for decision-making, seeking clinicians as an emotional support, and seeking referrals 
from clinicians for emotional support—were identified as ways previvors try to manage 
their uncertainties. Ultimately, previvors’ uncertainty sources and uncertainty 
management strategies impacted their health decision-making with preventative 
surgeries as the most common health decision. 
Overall, the purpose of this research was to gain insight into previvors’ uncertain 
health experiences in order to improve patient-centered communication between 
previvors and clinicians and ultimately better previvors’ health and well-being.  This 
research contributes to the literature by extending the exploration of uncertainty 
management to a new population, reinforcing the belief that chronic uncertainty should 
be managed not reduced, supporting health and illness uncertainty theories, and 
providing practical recommendations for clinician-patient communication.   
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
“Cancer is still a word that strikes fear into people’s hearts, producing a deep sense of 
powerlessness. But today it is possible to find out through a blood test whether you are 
highly susceptible to breast and ovarian cancer, and then take action.” 
 ~ Angelina Jolie 
On May 14, 2013 Angelina Jolie, an Oscar winning actress, film director, and 
humanitarian, wrote an op-ed for The New York Times, called “My Medical Choice.”  In 
this article, she disclosed that she “carr[ies] a ‘faulty’ gene, BRCA1, which sharply 
increases [her] risk of developing breast cancer and ovarian cancer” (par. 2).  Having 
this gene mutation in addition to her family history of cancer means she has an 87 
percent risk for developing breast cancer and a 50 percent risk for developing ovarian 
cancer during her lifetime.  Because of this gene, Angelina decided to “be proactive and 
to minimize the risk as much as [she] could” (par. 5) by undergoing a prophylactic 
double mastectomy.1  Doing so remarkably reduced her risk for breast cancer from 87 
percent to 5 percent (Jolie, 2013)! 
Angelina Jolie is not the only woman who has made this medical decision.  In 
2004, Jessica Queller, a writer and producer for the TV shows “Gilmore Girls” and 
“Gossip Girl,” discovered she had the BRCA1 gene mutation and a few years later had a 
                                                
1 A prophylactic double mastectomy is the surgical removal of one’s natural breasts in order to prevent a 
cancer.  
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prophylactic mastectomy (Queller, 2008).  In 2012, Sharon Osborne, the wife of Ozzy 
Osborne, former “X Factor” judge, and now co-host of CBS’s “The Talk,” revealed her 
prophylactic double mastectomy decision after learning her high risk for breast cancer 
(“Osbourne Mastectomy,” 2012).  And most recently, Miss DC and a 2013 contestant 
for Miss America, Allyn Rose, revealed she intends to have a prophylactic mastectomy 
after completing the 2013 pageant (“Rose Mastectomy,” 2013).  
Angelina Jolie, Jessica Queller, Sharon Osborne, and Allyn Rose are examples of 
previvors.  A previvor refers to an individual who is highly predisposed to breast or 
ovarian cancer due to a genetic mutation called BReast CAncer1 (BRCA1) and BReast 
CAncer2 (BRCA2) (Friedman, Sutphen, & Steligo, 2012; Roth Port, 2010).  The term 
“previvor” was coined by the organization Facing Our Risk of Cancer Empowered 
(FORCE) in 2000.  FORCE is a non-profit organization that seeks to improve both 
previvors and their family members’ lives through raising awareness and educating 
individuals about hereditary cancer and advocating for advancements in cancer 
prevention, detection, treatment, and quality-of-life (“Mission,” 2013).  
Having an organization that focuses on assisting previvors and their families 
make informed decisions about their health are essential for several reasons.  For one, 
previvors’ stories emphasize the fear, the anxiety, the waiting, and the unknown.  
Previvors experience and must deal with multiple and daily triggers of uncertainty about 
their future.  Previvors contemplate their own genetic risk, agonizing over what to do 
given new information about their genetic make-up.  
  3 
Experiences like these raise important questions.  What does a previvor’s health 
experience look like? Is it different than a breast or ovarian cancer patient or a survivor?  
How does it feel to have, as many women put it, “ticking time bomb boobs?”  What 
petrifies a previvor more—losing one’s femininity through the removal of her breasts or 
ovaries or not being around to watch her children grow up?  And how does a previvor 
deal with not knowing what her future path will encompass?   
Angelina, Jessica, Sharon, and Allyn’s stories exemplify one pathway for 
answering these questions.  For these four women, the pathway included finding out 
whether or not they had a high genetic risk for developing breast and ovarian cancer at 
some point in their lives, and when that risk was confirmed, they decided to proactively 
minimize their risk by undergoing prophylactic or preventative mastectomies (Jolie, 
2013; Queller, 2008; “Osbourne Mastectomy,” 2012; “Rose Mastectomy,” 2013).   
However, this is not the only pathway for coping with a terrifying and uncertain 
future of hereditary cancer.  In addition to preventative surgeries, individuals may also 
choose to ignore their family history of breast and ovarian cancer and not even be tested.  
Or individuals may be tested, and then once they discover they have a positive genetic 
mutation, they may choose to completely ignore the results and try to not worry about 
their high risk.  Or lastly, individuals may discover they are positive BRCA gene carriers 
but not opt for prophylactic surgeries and instead engage in measures such as increased 
detection or even chemoprevention.  In short, individuals make decisions about their 
uncertain futures in many different ways (Friedman, Sutphen, & Steligo, 2012; Roth 
Port, 2010).   
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The purpose of this dissertation is threefold.  First, I seek to identify previvors’ 
types or sources of uncertainty.  Second, I want to learn what strategies previvors utilize 
to cope with those uncertainties, and finally, I seek to understand how previvors’ 
uncertainties influence what type of health decisions they make and how those decisions 
affect their subsequent sense of uncertainty.   
What is a Previvor? 
A previvor is an individual who is highly predisposed to developing breast or ovarian 
cancer due to an inherited genetic mutation called BReast CAncer1 (BRCA1) and 
BReast CAncer2 (BRCA2), commonly known as “the breast cancer gene.”2  The BRCA 
gene was discovered in the mid-1990s, and these mutations are inherited.  Testing 
positive means the following:  
• You inherited a genetic mutation from one of your parents.  
• You have increased risk for breast, ovarian, and other cancers.  
• Your biological siblings have a 50 percent chance of having the same mutation.  
• Your cousins, aunts, uncles, and other blood relatives (on the side of the family 
from which you inherited the mutation) may have the same mutation.  
• Your biological children have a 50 percent chance of inheriting your mutation 
(Friedman, Sutphen, & Steligo, 2012, p. 67; (see Appendix C for a list of 
technical terms).   
                                                
2 BRCA gene mutations are only responsible for causing approximately five to ten percent of breast 
cancers and 12 percent of ovarian cancers.  	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An individual’s risk is the key to understanding one’s chance of developing 
breast and/or ovarian cancer during one’s lifetime.  A risk factor is anything that makes 
an individual more susceptible to developing a disease than other individuals (Roth Port, 
2010).  Individuals are more likely to have a positive BRCA gene mutation and thus 
have an increased risk of developing cancer if one or more of the following controllable 
risk factors (e.g., weight, diet, physical activity, alcohol consumption) and/or 
uncontrollable risk factors are true (e.g., gender, age, race/ethnicity, genetics).  I first 
discuss the risk factors that are not in an individual’s control.  
Gender, age, race/ethnicity, and genetics are the first four uncontrollable risk 
factors.  According to Friedman, Sutphen, and Steligo (2012), first, simply being a 
woman enhances the risk for developing breast and ovarian cancer, although men can 
also be diagnosed with breast cancer and are at risk if they carry the gene mutation.  
Second, an individual’s age influences the likelihood of acquiring abnormal changes in 
one’s breast or ovaries.  In other words, one’s risk increases with age.  The third 
uncontrollable risk factor is race/ethnicity.  Individuals of Ashkenazi Jewish heritage are 
the most likely to develop breast cancer followed by, but not too closely, White or 
Caucasian women and then African-American women (2012). 
In addition to these demographic risk factors, a fourth risk factor is genetics.  
Though a small number of breast and ovarian cancer diagnoses are due to a genetic 
mutation, individuals who test positive for either the BRCA1/2 gene mutation have a 
high risk for developing cancer in their lifetime.  An individual’s chance of having a 
positive gene mutation is higher when any family member has had either ovarian, 
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primary peritoneal, or fallopian tube cancer at any age, or if a male family member has 
been diagnosed with breast cancer despite age, and/or if there are multiple diagnoses in a 
family on the same side (Friedman, Sutphen, & Steligo, 2012).  
The sixth risk factor, according to the same authors, is personal health and cancer 
experiences.  Being diagnosed with cancer in one breast increases the likelihood of 
acquiring cancer in the other breast or even a different part of the original breast.  Also, 
abnormal breast biopsy results increase risk of breast cancer.  For instance, a woman 
who finds benign breast cells often raises her risk because the cells are proliferate, 
meaning they multiple quickly.  Additionally, personal radiation exposure increases a 
woman’s risk of developing cancer because it can cause cancer especially when exposed 
during adolescence (2012). 
The seventh risk factor is a woman’s breasts and hormones.  Breast density and 
hormone levels enhance the likelihood of being diagnosed with breast cancer in one’s 
lifetime.  A woman who has dense breasts has more breast tissue to fat and thus is more 
likely to develop cancerous cells. Also, hormone-related issues are a risk.  The more 
estrogen in a woman’s body increases the likelihood that mutated breast cells will grow 
cancerous (Friedman, Sutphen, & Steligo, 2012). 
Finally, Roth Port (2010) explains a few of the risk factors that women may have 
some control over.  For one, gaining weight as an adult in post menopause increases 
breast cancer risk.  So individuals who exercise regularly can reduce their breast cancer 
risk because exercising lowers the estrogen levels in the body and also helps control fat 
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content.  Further, a low-fat diet can also reduce an individual’s risk.  Lastly, limiting 
consumption to one drink a day can also slightly reduce one’s breast cancer risk.  
Yet even with all of these known risk factors, it is difficult to determine the exact 
amount of one’s risk for developing breast and ovarian cancer.  Currently, there is no 
specific way for experts to determine a woman’s “exact” risk because it is difficult to 
calculate due to the many possible uncontrollable and controllable risk factors (Bylund 
et al., 2012; Roth Port, 2010).  It is still unclear why some people have mutations and are 
diagnosed with cancer while others have the mutation and never contract the disease.  
Furthermore, specialists cannot predict when cancer may develop for individuals with a 
genetic mutation or how those individuals may respond to different types of treatment. 
Nevertheless, discovering BRCA1/2 gene mutations is “important in identifying high-
risk individuals and finding ways to reduce their breast and ovarian cancer risk” 
(Friedman, Sutphen, & Steligo, 2012, p. 12).    
Presently, specialists can only offer women and their families a vague range 
between 44 to 87 percent risk for developing cancer (Roth Port, 2010).  According to 
recent estimates, individuals who test positive for BRCA1 have a 55 to 65 percent risk 
for breast cancer and a 39 percent risk for ovarian cancer, while individuals who test 
positive for BRCA2 have around a 45 percent risk for breast cancer and an 11 to 17 
percent risk for ovarian cancer (Chen & Parmigiani, 2007; Howlader et al., 2013).  
Again, these statistics vary based on uncontrollable and controllable factors such as 
family history of cancer.  However, researchers hope and believe that sooner than later 
they will be able to assess women’s individual risk more precisely (Roth Port, 2010).  
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In summary, a previvor refers to an individual who is highly predisposed to 
developing breast and ovarian cancer during one’s lifetime due to the genetic mutation 
BRCA1/2.  Having one of these genetic mutations in addition to understanding personal 
risk factors assists in revealing a previvor’s likelihood of being diagnosed with cancer.  
Nonetheless, even with recent scientific advancements in genetics and cancer, previvors 
still do not know their exact risk because of the various risk factors associated with 
cancer.  Thus, a previvor’s life is ridden with uncertainty.  
Why Uncertainty? 
Uncertainty manifests in many different ways for previvors.  As noted 
previously, previvors experience uncertainty and fear about an unknown diagnosis and 
must face daily reminders of the high possibility of developing cancer.  Moreover, after 
discovering one’s genetic predisposition, previvors must then wrestle with how to 
protect their health and secure their future.  So often in an attempt to cope, previvors 
engage in different types of strategies for reducing and managing their uncertainties, yet 
with each coping strategy, it becomes clear that being a previvor means one is never 
quite free of an uncertain future.  Such a conclusion points to the importance of 
examining uncertainty within this particular population and how it is people come to 
manage the uncertainty.  
Research reveals that within medical encounters uncertainty cannot ever be 
entirely eliminated (Epstein & Street, 2007), and inadequately managed uncertainty in 
clinical encounters can have detrimental psychosocial effects (Neville, 1998).  When 
uncertainty is managed poorly, and an individual has inadequate coping resources and 
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mechanisms, emotional distress often results (e.g., anxiety, stress, depression, etc.) 
(Arora, 2003; Lee, 2006; Lien, Gau, Hsu, & Chang 2009; Shaha et al., 2008; Stewart, 
Lynn, & Mishel, 2010).  Other negative consequences of uncertainty in cancer care 
include loss of control or sense of control, low resourcefulness, and lower quality of life 
(Andreassen et al., 2005; Dirkson, 2000; Dunn et al., 1993; McWilliams, Brown, & 
Stewart, 2000).  
 Additionally, uncertainties regarding illness can complicate relationships with 
clinicians, family members, friends and even coworkers, which in turn can complicate 
treatment and aggravate the illness (Ford, Babrow, & Stohl, 1996).  Uncertainty can 
cause anxiety for clinicians and patients as well as lead to patient dissatisfaction and 
decision regret (Bosk, 1980; Curley et al., 1989; Johnson et al., 1988; Katz, 1984; 
Hershey & Baron, 1987).  Uncertainty also interferes with patients’ ability to construct 
meaning about illness-related events, resulting in poorer decisions and psychosocial 
adjustment (Christman et al., 1988; Fuemmeler, Mullins, & Marx, 2001; Mishel, 1999; 
Wong & Bramwell, 1992).  Finally, uncertainty can diminish standards of quality care, 
contribute to malpractice claims, and complicate the informed consent process 
(Beresford, 1991; Eddy, 1984; Eddy & Billings, 1988; Gutheil, Bursztajn, & Broadsky, 
1984; Mirvis & Chang, 1997).  Hence, there is a need to explore and understand the 
nature of uncertainty and the strategies that can assist previvors in managing uncertainty.   
Unfortunately, despite psychological and physical morbidity associated with 
uncertainty, little is known about what clinicians can do to reduce distress and anxiety 
related to uncertainty.  Thus, this dissertation expands understanding about managing 
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uncertainty in cancer care to a new population—previvors.  Through this research, I 
hope to provide clinicians with specific ways to assist previvors in coping and tolerating 
uncertainty about a future cancer diagnosis and present previvors with information about 
managing uncertainty in order to make health-related decisions.  Now that I have 
explained what it means to be a previvor and why it is important to examine previvors’ 
management of uncertainty, I turn to discussing relevant literature to the present topic. 
Literature Review 
In this section, I seek to accomplish three objectives.  First, I define uncertainty, 
noting theories of uncertainty management and sources for uncertainty. Second, I discuss 
patient-centered communication especially as it relates to managing uncertainty in 
clinical encounters. Third, I discuss different strategies for managing uncertainty.  
It is important to note that even though I am interested in previvors’ management 
of uncertainty in clinical encounters, it is necessary to have a broad understanding of 
uncertainty in cancer care. As such, in my literature review, I draw on relevant research 
about cancer patients and cancer survivors as well as cancer previvors. I first define 
uncertainty, explaining three important uncertainty management theories of health and 
illness.   
Uncertainty and the Management of Uncertainty 
Uncertainty fluctuates through cancer stages (Mishel et al., 2003), and often it 
cannot be completely eliminated (Epstein & Street, 2007).  Individuals diagnosed with 
cancer often experience significant emotional distress and uncertainty, which can have 
negative impacts on patient health outcomes (Arora, 2003).  For example, cancer 
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patients must deal with an overwhelming amount of medical information and then make 
difficult treatment decisions (Epstein & Street 2007).  Cancer survivors experience 
uncertainty and anxiety at the end of the treatment when moving into the survivorship 
phase (Becze, 2009; Epstein & Street, 2007).  Cancer previvors are faced with 
uncertainty and emotional distress because of a possible future cancer diagnosis and 
must make decisions regarding genetic testing as well as possible preventative actions 
and lifestyle changes (Pasacreta, 2003).  These are but a few examples of medical 
decisions that include unknown or uncertain clinical evidence regarding possible risks 
and benefits that guide clinical decisions (BMJ Clinical Evidence, 2007).  
Uncertainty Defined 
Uncertainty is inherent in health contexts and has been conceptualized in several 
different ways.  Originally, uncertainty was conceptualized as something that needed to 
be (and could be) reduced or eliminated (Babrow & Kline, 2000; Berger & Calabrese, 
1975; Bylund et al., 2012).  From this perspective, uncertainty is viewed as a 
“dispreferred state,” and individuals can reduce such cognitive and behavioral 
uncertainty states through passive, active, and interactive strategies (Berger, 1987; 
Berger & Calabrese, 1975).   
Yet after subsequent studies, scholars have realized that uncertainty is more 
complex than previously thought (Bylund et al., 2012; Epstein & Street, 2007).  Since 
then other scholars in medicine and communication have grappled with defining 
uncertainty, building on its original definition especially as it relates to information.  
Broadly, uncertainty exists when an individual believes certain aspects of a situation 
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(e.g., health illness or issue) is ambiguous, inconsistent, too complex, unknown or 
unclear, and/or unpredictable or random; when information is inconsistent or even 
unavailable; or when the individual is insecure about the amount of information and thus 
knowledge she has about the situation or issue (Babrow, Hines, & Kasch, 2000; Babrow, 
Kasch, & Ford, 1998; Brashers, 2001; Mishel, 2005). From this perspective, uncertainty 
is a state of knowledge that an individual possesses or lacks (Babrow, Hines, & Kasch, 
2000; Babrow, Kasch, & Ford, 1998), and the lack of information is, to some degree, 
independent of the knowledge an individual possesses.  In other words, though an 
individual may have all possible information on a particular issue, she may still feel 
uncertain (Brashers, 2001).  
Uncertainty is also defined based on the probability that an event might occur 
(Babrow, 1992).  Individuals experience uncertainty when the “likelihood of the event 
occurring or not occurring becomes equal.  If multiple alternatives are possible, 
uncertainty is highest when all events seem equally probable” (Brashers, 2001, p. 479).  
Similarly, an important component of uncertainty for Han (2013) is probability, which 
refers to randomness of possible future outcomes and events.  So uncertainty is “the 
subjective consciousness of ignorance,” or a “‘metacognition’—a thinking about 
thinking—characterized by self-awareness of incomplete knowledge about some aspect 
of the world” (p. 16S).   
The above viewpoints of uncertainty clearly reveal a bias towards information.  
Much of research on uncertainty assumes uncertainty stems from a lack of information, 
but uncertainty can also be created by too much information or when information that is 
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available has multiple interpretations (Epstein & Street, 2007).  This point reinforces the 
idea that uncertainty cannot simply be reduced, but sometimes must be maintained or 
even increased in order to preserve and/or produce psychological well-being and good 
health (Brashers et al., 2000; Epstein & Street, 2007).  
Despite varying definitions of uncertainty, there are three important theories to 
consider that seek to explain the nature of uncertainty in the health care context—the 
theory of uncertainty in illness (Mishel, 1988), theory of communication and uncertainty 
management (Brashers et al., 2000, 2003), and problematic integration theory (Babrow, 
1992).  I first describe Mishel’s theory of uncertainty in illness.  
Theories of Uncertainty in Health 
 The theory of uncertainty in illness states uncertainty is produced when an 
individual’s present experience regarding the nature of illness lacks a complete cognitive 
representation.  In other words, some component(s) of the illness event are missing such 
that an individual does not have a sufficient understanding of factors related to her health 
and well-being (Mishel, 1988).  There are three important components of this 
uncertainty.  The first component, symptom pattern, refers to an individual’s ability to 
recognize symptom patterns regarding her intensity, frequency, predictability, and 
expected outcomes.  Event-familiarity, the second component, is the ability to organize 
an illness event within the context of a time and place.  Lastly, event-congruence refers 
to an individual’s ability to comprehend an illness-related event and understand the 
probability of the outcome occurring.   
 Thus, according to this theory, when a patient like a previvor is uncertain, she is 
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not able to form cognitive representations for her illness due to little or no information, 
knowledge, or experience with the symptoms, her significance, and/or how to manage 
the problem (Mishel, 1988; Mishel & Braden, 1988).  Failure to effectively manage this 
uncertainty can result in poor decision-making, negative psychosocial consequences, and 
lower quality of life (Christman et al., 1988; Fuemmeler et al., 2001; Mishel, 1999; 
Wong & Bramwell, 1992).  Yet in order to effectively manage the uncertainty, previvors 
need to perceive their clinicians as credible sources for information in helping them 
comprehend and make meaning out of their potential illness and the best course of 
therapeutic action (Mishel, 1990).  Individuals may also rely on other resources for 
understanding and interpreting issues related to their health including the Internet, print, 
audio, or video materials, friends and family, and cultural and religious beliefs (Sparks 
& Villagran, 2010).  In short, according to theory of uncertainty in illness, the 
relationship between uncertainty and stress is influenced by the vagueness of illness 
events and a lack of comprehensible and coherent information (Mishel, 1984).  
 The second theory speaks to communication and uncertainty management. 
According to Brashers and his colleagues (2000), uncertainty management means 
making specific choices based on the perceived threat and information.  In other words, 
individuals assess their uncertainty in order to determine potential harm and benefits.  
Such assessments are intertwined with emotions such as anxiety and worry but also hope 
and optimism.  Individuals’ assessments and emotional responses then produce possible 
routes of behavior and psychological actions to manage the experienced uncertainty.   
 There are two main types of uncertainty management—information seeking and 
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information avoidance (Brashers et al., 2003).  Though both strategies can assist in 
managing uncertainty, each has their own purposes.  The goal of information seeking is 
typically to reduce uncertainty, whereas the goal of information avoidance is to retreat 
from overwhelming or distressing information.  For instance, previvors might seek 
genetic testing to gain information about their possible high risk for cancer, while others 
might avoid genetic testing because they do not want to learn that information.   
 In this way, a key tenet of the theory of communication and uncertainty 
management is that uncertainty management is not equivalent to uncertainty reduction.  
For example, when the threat of information is perceived high, then individuals might 
seek out contrary information to then increase the uncertainty and ultimately reduce the 
threat (Brashers et al., 2000).  In short, successfully managing uncertainty involves “the 
negotiation of identity, relationships, levels of knowledge, and physical and 
psychological well-being” (p. 81).  
 The last theory is problematic integration (PI) theory.  This theory explains that 
individuals orient their lives in terms of expectations and evaluations; it seeks to 
understand how people seek information to manage their uncertainty when coping with 
an illness (Babrow, 1992, 1995, 2001).  There are two main components of PI theory—
probabilistic orientations and evaluative orientations.  Probabilistic orientations refer to 
the likelihood an event or issue may occur in an individual’s lifetime, while evaluative 
orientations refer to the assessment of the desirability of a possible outcome.  Evaluative 
orientations are rooted in emotions, but probabilistic ones are rooted in cognition. So 
problematic integration then occurs when the expectations individuals have and the 
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evaluations individuals think will occur are uncertain.  Said differently, uncertainty 
arises when individuals’ judgments about the likelihood of wanted or unwanted 
outcomes are incompatible (Babrow, 2001; Sparks & Villagran, 2010).   
 PI theory offers several advantages to understanding uncertainty in clinical 
encounters. One advantage is it provides clinicians with multiple explanations for 
different kinds of uncertainties that can coexist on many levels (Hines et al., 2001).  For 
example, a cancer previvor may be uncertain about what preventative course of action to 
take (e.g., increased detection, chemoprevention, or prophylactic surgeries).  This 
uncertainty may exist because, on one level, the previvor is overwhelmed with the 
amount of information provided for each preventative choice; while at the same time, 
she may be uncertain about whether the chosen option will reduce her risk of cancer.  
Second, PI theory assists in understanding the relational context of uncertainty as 
previvors and clinicians must work through the uncertainty together to achieve a shared 
understanding of the problem and ultimately take appropriate actions to address the 
problem.  Third, it emphasizes the importance of communication as a resource for 
coping or managing uncertainty.  In brief, PI theory explains that the emotional and 
cognitive aspects of uncertainty are managed, if not resolved, communicatively because 
clinicians and patients co-work to make sense out of the patient’s health state and the 
best course of therapeutic action  (Sparks & Villagran, 2010).  
 Taken together, these theoretical perspectives emphasize three important aspects of 
health-related uncertainty (Bylund et al., 2012).  First, although uncertainty at any one 
point in time may be reduced and sometimes eliminated, more often it ebbs and flows 
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over time.  For instance, a cancer previvor’s uncertainty about a preventative choice may 
be reduced after the preventative course is completed; however, a different form of 
uncertainty may emerge when she is no longer actively participating in preventing the 
cancer and consequently worrying about the future.  Second, people differ in their 
preferences for managing uncertainty such that sometimes individuals choose to 
maintain or even increase their uncertainty as a coping mechanism (Bylund et al., 2012).  
For example, a previvor may know her mother has tested positive for the BRCA1/2 gene 
mutation but decide not to be tested because she does not want to be burdened with the 
knowledge of having the mutation.  Lastly, uncertainty cannot always be eliminated and 
therefore must be managed communicatively.  Within these relationships, people will 
make various decisions to cope with and to manage the uncertainty in an effort to 
maximize their health and well-being (Epstein & Street, 2007).  Thus, after 
conversations with families and clinicians, a cancer previvor may undergo genetic 
testing, engage in more diligent preventive and screening behavior, and ponder future 
prophylactic actions in an effort to achieve some peace of mind about a health condition 
that has an uncertain future.   
Types, Reasons, and Sources of Uncertainty 
 To satisfactorily manage health-related uncertainty, it is important to understand 
the reasons and sources of the uncertainty.  There are several sources that create 
uncertainty about cancer and other chronic diseases, much of which relate to the amount 
or quality of available information in that uncertainty; such uncertainty can be created by 
too little information, complicated or conflicting information, and/or too much 
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information (Brashers, 2001; Epstein & Street, 2007; Mishel, 1999; Shaha et al., 2008).  
First, there can be uncertainty related to the likelihood of future health states.  Stochastic 
uncertainty refers to being uncertain about future outcomes or events related to an illness 
and/or its treatment (Edwards, Elwyn, & Mulley, 2002; Politi & Street, 2011; Politi, 
Lewis, & Frosch, 2013).  For example, how likely is it that a previvor will develop 
cancer or that a cancer treatment can cure the disease.  Second, ambiguity uncertainty is 
defined as uncertainty related to conflicting evidence or the strength of the evidence 
generating risk information.  For instance, missing or inconsistent data, differences in 
study results, and conflicting clinical recommendations produce such ambiguity (Politi, 
Lewis, & Frosch, 2013; Politi & Street, 2011; Politi et al., 2007).  Lastly, informational 
uncertainty is caused by unusable, inapplicable, or even unavailable scientific data in a 
clinical encounter that is a function of ambiguity (Politi, Lewis, & Frosch, 2013).  For 
example, a treatment might be relatively new and thus clinical evidence lacking (Truog 
et al., 2008), and this unavailable data might cause clinicians to feel unprepared to talk 
about the new treatment with the patient (Brehaut et al., 2008; Davison et al., 2006).  
 Much of the current research on health-related uncertainty focuses on 
communicating risk.  According to Roth Port (2010), there are two types of risk:  
Absolute risk is the odds a person will develop breast cancer over a specific time 
period. For example, you can determine your odds in the next year, the next five 
years, or throughout your lifetime. So when you hear the well-known statistic that 
one in eight women will develop breast cancer during their lifetime, that’s an 
absolute risk.  
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Relative risk shows the relationship between a risk factor and breast cancer by 
comparing a group of people who have that particular risk with people who don’t 
(p. 36, emphasis in original).   
Thus, in the clinical encounter, communication about uncertainty often focuses on 
helping patients understand their perceived risk.  By doing so, clinicians and patients are 
able to explicate the different types of sources for uncertainties related to patients’ 
likelihood of future health states. 
 Politi, Han, and Col (2007) identify the following sources of such uncertainty:  
1) risk, or uncertainty about future outcomes; 2) ambiguity, or uncertainty about 
the strength or validity of evidence about risks; 3) uncertainty about the personal 
significance of particular risks (e.g., their severity timing); 4) uncertainty arising 
from the complexity of risk information (e.g., the multiplicity of risks and benefits 
or the instability of risks and benefits over time); and 5) uncertainty resulting from 
ignorance (p. 682).   
 Since then, Han and his colleagues (2011) have extended conceptions of health-
related uncertainty to include the decision making process and medical and the 
organizational features of health care providers.  According to Han et al., uncertainty 
exists on a continuum from disease-centered to patient-centered.  Disease-centered 
uncertainty focuses on scientific or data-centered issues including diagnosis, prognosis, 
causal explanations, and treatment recommendations (e.g., risk information, probability 
of outcome).  The next is practical or system-centered uncertainty related to the 
structures and care processes (e.g., what care does the previvor need and how does she 
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get it).  Lastly, personal or patient-centered uncertainty refers to psychosocial and 
existential issues and concerns related to a patient’s unique situation and how she 
perceives and manages the uncertainty (e.g., coping, preventive actions, spirituality).  
 Overall, health-related, unmanaged uncertainty is caused by several sources, 
centers around different illness issues, and produces negative outcomes.  Uncertainty 
stems from potential unknown outcomes, ambiguous symptoms, the unpredictable 
course of the illness, the treatment and recovery’s intensity and timing, and concerns 
regarding the cancer’s long-term impact on social, cognitive, and emotional competence.  
Such uncertainty results in negative psychosocial effects including emotional distress, 
low quality of life, poor decisions, and loss of control.  As such, clinicians and patients 
must communicate effectively to manage health-related uncertainty.  Thus, I turn to 
discussing managing uncertainty as a function of patient-centered communication.  
Patient-centered Communication Functions 
Because uncertainty can be problematic when it is not managed, there is a need to 
effectively communicate about uncertainty in health contexts.  To explore uncertainty, a 
functional approach to communication is helpful. Such approach focuses on the key 
tasks or ‘work’ communication must do well in order to achieve the interaction’s goals 
(Street & de Haes, 2014).   
While there could be any number of important communicative tasks in cancer care, 
Epstein and Street (2007) identify six key functions—effective information exchange, 
fostering healing relationships, responding to emotions, making quality decisions, 
enabling patient self-management, and with respect to this dissertation, managing 
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uncertainty.  These key functions are especially important because they emphasize 
meeting patients’ needs and impact health outcomes within the clinical encounter.  Yet 
before I present this six-function model of patient-centered communication, it is 
important to note that these functions overlap and thus are not independent from one 
another.  Consequently, I will talk about each of the functions within the context of the 
function managing uncertainty, as this is the most important function to the present 
dissertation. 
The first function of effective patient-clinician communication is managing 
uncertainty (Epstein & Street, 2007).  Uncertainty is significant in cancer care because 
outcomes occur close to diagnosis, and cancer is typically curable.  Additionally, 
uncertainty manifests in several stages of cancer (Mishel et al., 2003).  A cancer patient 
who receives a cancer diagnosis is uncertain about which treatment course to take.  A 
cancer survivor ending treatment is uncertain about the possibility of recurrence.  A 
cancer previvor is uncertain about which preventative course to take after testing 
positive for a genetic mutation.  
Given these uncertainties are associated with the different stages of cancer, 
uncertainty is often irreducible and thus, clinicians must assist patients in managing their 
uncertainty instead.  To manage uncertainty, clinicians can acknowledge uncertainty 
exists, frame information based on what is known and unknown, be empathetic and 
engage in active listening, and teach patients coping techniques to personally assist them 
in their day-to-day lives (Epstein & Street, 2007).  Unfortunately, managing uncertainty 
is one of the least understudied and problematic elements of patient-centered 
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communication (Decker, Haase, & Bell, 2007; Epstein & Street, 2007; Politi & Street, 
2011), and the specific strategies with which to manage uncertainties in cancer is poorly 
understood (Bailey et al., 2004; Mishel, 1999). 
Each of the other patient-centered communication functions helps address issues 
related to managing and coping with uncertainty.  For example, the second core 
function—information exchange (Epstein & Street, 2007)—is important to managing 
uncertainty as some sources of uncertainty are associated with information.  Information 
exchange includes seeking or gathering information, giving information, verifying 
information, checking for understanding, and reaching agreement on medical decisions 
and plans (Cegala, Coleman, & Turner, 1998; Cegala, 1997).  Both clinicians and 
patients must present and manage information with each other in order to reach a shared 
understanding of patients’ health (Epstein & Street, 2007).  Also, providing information 
enhances satisfaction, facilitates more participation, decreases anxiety, and increases 
coping abilities (Davidson & Mills, 2005; Arraras et al., 2004).  In order to effectively 
exchange information, clinicians must learn patients’ information needs, understand their 
health beliefs and values, and present clinical information in understandable ways 
(Epstein & Street, 2007).   
For previvors, obtaining and understanding information from clinicians about their 
genetic risk can assist in managing their uncertainty about the possibility of a future 
cancer diagnosis (McCormack et al., 2011; Politi & Street, 2007).  Information about 
risk probabilities, preventative options, and outcomes can assist previvors in making 
choices about their health risk.  Furthermore, understanding information about what is 
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“known” versus “unknown” as it relates to cancer risk and the risks and benefits of 
different types of preventative options may also reduce future uncertainty (Epstein, 
Alper & Quill, 2004; Epstein & Street, 2007). 
The third core function of effective clinician-patient communication is fostering 
healing relationships (Epstein & Street, 2007).  Fostering such relationships between 
clinicians and previvors contributes to managing uncertainty by demonstrating to 
previvors that they will not be abandoned as well as showing them their clinicians will 
support them throughout their entire journey. To foster such relationships, patient-
centered communication must build rapport and create trust between previvors, their 
families, and their clinicians.   
Several factors can help produce strong relationships between clinicians and patients 
including trust, respect, shared understanding of roles and responsibilities, and clinician 
self-awareness and well-being.  First, trust must be mutual.  Patients trust their clinicians 
when they believe their clinicians are informative, include them in the decision-making 
process, and are sensitive to their concerns (Gordon, Street, Sharf, Kelly, & Souchek, 
2006; Salkeld, Solomon, Short, & Butow, 2004).  Second, building rapport, or 
connecting with patients through verbal and nonverbal communication, leads to 
satisfactory relationships (Tickle-Degnen & Rosenthal, 1990).  Third, clinicians and 
patients must understand each other’s roles and responsibilities by learning and 
comprehending each other’s preferences (Krupat, Yeager, & Putnam, 2000).  Lastly, 
clinicians should build partnerships, listen actively, ensure patient understanding, display 
empathetic nonverbal behaviors, and engage in joint agenda setting with the patient 
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(Street, Gordon, Ward, Krupat, Kravitz, 2005; Street, Voigt, Geyer, Manning, & 
Swanson, 1995; Williams & Deci, 2001).  By fostering such relationships through these 
strategies, clinicians can help previvors cope and mange their uncertainty about the 
future.  
The fourth core function is responding to emotions (Epstein & Street, 2007).   
Patients experience a variety of emotions during clinical encounters, and many are 
important to providing quality health care.  For example, previvors who have a high risk 
of being diagnosed with cancer must constantly deal with its imminent threat and thus 
experience negative emotions such as fear, worry, frustration, depression, and anger.  
Because these emotional states can have negative effects on individuals’ physical health 
and overall well-being, clinicians must first recognize and then respond to the emotions 
(Dean & Street, 2014).   
To respond to emotions, clinicians can employ both verbal and nonverbal 
communication behaviors to recognize the displayed emotion, ask questions to 
understand the emotional state, communicate that understanding, and then respond with 
empathy and/or, depending on the degree of the emotion, provide referrals and engage in 
interventions (Epstein & Street, 2007).  Unfortunately, clinicians have a difficult time 
identifying and thus assisting their patients in managing negative emotions due to a 
variety of reasons (Dean & Street, 2014).  Some of those reasons include the following: 
not having the skills to recognize or respond to the emotions, thinking it is someone 
else’s responsibility, or worrying that talking about the emotions will cause further 
distress for the patient (Butow, Brown, Cogar, & Tattersall, 2002; Ryan et al., 2005; 
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Zimmerman, Del Piccolo, & Finset, 2007).  Yet, clinicians who work with previvors 
(e.g., oncologists, genetic counselors, gynecologists, etc.) must learn to overcome such 
challenges, acknowledge their role in identifying negative emotions, and enact the above 
strategies to enhance the recognition of emotional distress (Dean & Street, 2014).  
The fifth core function is making decisions (Epstein & Street, 2007).  Decision-
making is essential to any patient-clinician interaction but especially those in cancer 
care.  Previvors must make decisions about which preventative course to choose after 
testing positive for the BRCA gene mutation in order to help manage their anxiety about 
possibly developing cancer during their lifetime.  Effective decision-making includes 
three main steps—information exchange, deliberation, and the final decision (Charles, 
Gafni, & Whelan, 1999).  A high-quality decision includes identifying and 
understanding patients’ preferences.  However, clinicians often do not know their 
patients’ needs and values, and patients may not know or understand all treatment 
options (Epstein & Street, 2007).   
Furthermore, patients vary on the desired degree of participation in clinical 
interactions (Janz et al., 2004).  Decision-making can either be paternalistic (e.g., the 
clinician decides), shared (e.g., the clinician and patient decide together), or informed 
(e.g., the patient decides given provided information from clinician and other sources) 
(Charles, Gafni, & Whelan, 1999).  To enact patient-centered decision-making, 
clinicians should actively listen, set an agenda, check understanding, offer involvement 
opportunities, encourage patient participation, accommodate preferences, and 
communicate empathy and warmth (Epstein & Street, 2007).  Engaging in such 
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strategies will assist previvors in enacting effective decision-making but also managing 
uncertainties about the many preventative health options.  
The sixth function is enabling patient self-management (Epstein & Street 2007).  
Self-management is the perceived ability to self-manage one’s illness through navigating 
the healthcare system, seeking information, coping with side effects, and finding help 
when needed (Bodenheimer, Wagner, & Grumbach 2002; Bodenheimer et al., 2002; 
Epstein & Street 2007).  Management or enablement encompasses both tasks clinicians 
can perform for their patients that may eliminate barriers to self-management and 
strategies clinicians can engage in to assist patients in caring for themselves outside of 
the clinical encounter.  Important here is the difference between information exchange 
and self-management.  Self-management specifically emphasizes recommendations, 
instructions, and advocacy; whereas, information exchange includes sending and 
receiving content about a topic (Epstein & Street 2007).   
Engaging in self-management skills can assist previvors in managing their 
uncertainty. For instance, clinicians may need to act or advocate on the behalf of their 
previvors in order to help them navigate the health care system (e.g., coordinate care, 
arrange referrals), support patient autonomy to enhance patient self-efficacy and 
motivation (Deci & Ryan, 1985), and provide guidance and skills as well as access to 
resources (e.g., Internet, health educators, or interactive media) (Epstein & Street, 2007).  
Doing so enables previvors to cope with the various uncertainties outside clinicians’ 
offices and facilities.  
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In summary, patient-centered communication encompasses managing 
uncertainty, exchanging information, fostering healing relationships, responding to 
emotions, making quality decisions, and enabling self-management, and these functions 
of communication overlap and work together to achieve certain goals in order to meet 
needs and impact health outcomes, as demonstrated through the uncertain experience of 
previvors.  
Communicative Strategies for Managing Uncertainty 
 From this patient-centered communication perspective, specific strategies can be 
derived in order to assist in tolerating, coping, and managing uncertainty (Babrow & 
Kline, 2000; Brashers, 2001; Politi & Street, 2011). Providing useable and meaningful 
information, offering support, and engaging in cognitive coping techniques are but a few 
examples of the different communicative strategies that can assist both clinicians and 
patients and their families in dealing with uncertainty (Epstein & Street, 2007).  In this 
section, I categorize communicative actions for managing uncertainty into the following 
three types of strategies: 1) cognitive strategies, 2) affective strategies, and 3) behavioral 
strategies (McCormack et al., 2011).   
 Before discussing specific communicative strategies for managing uncertainty, it is 
important to note the quality of the patient-clinician relationship specifically as it relates 
to trust and shared understanding plays an important role in helping patients (and 
clinicians) manage uncertainty (Arora, 2003; Mishel et al., 2005; Politi & Street, 2007; 
Quill & Suchman, 1993).  Engaging in patient-centered communication strategies such 
as validating patients’ uneasiness with uncertainty, involving patients in decision-
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making, and clarifying values and goals can assist in reducing the negative health 
impacts of communicating uncertainty (Han, 2013; Politi & Street, 2011).  Furthermore, 
since patients and clinicians often differ in how they experience uncertainty (Richardson, 
Masse, Nanny, & Sanders, 2004), clinicians must acquire some insight, either directly or 
indirectly, regarding patients’ preferences in order to determine how best to deal with 
both short-term and long-term patients’ uncertainty (Hoff & Hermeren, 2011).  
Cognitive Strategies for Managing Uncertainty 
 The first domain for managing uncertainty is cognitive.  Cognitive strategies for 
managing uncertainty include skills such as cognitive reframing, problem solving, and 
the provision of information.  These cognitive strategies target uncertainty caused by 
unexpected or inconsistent triggers and thus are important because they assist in creating 
shared understanding for why uncertainty exists (Mishel et al., 2005; McCormack et al., 
2011).  
 Cognitive reframing is the ability to address concerns and issues from an 
optimistic perspective.  Cognitive reframing skills include self-talk, relaxation, pleasant 
imagery, and distractions.  By using these skills and strategies, cancer patients, 
survivors, and previvors can manage their uncertainty when it is triggered (Mishel et al., 
2002, 2005).  For example, a cancer survivor may feel heightened uncertainty when she 
hears a media story about breast cancer, or a cancer previvor might experience increased 
anxiety about possible cancer when attending her annual mammogram check-up.  On the 
other hand, enacting problem solving then uses those learned cognitive coping skills to 
recognize and define concerns and produce possible solutions to those concerns (Mishel 
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et al., 2002, 2005).  In short, these strategies are effective in managing sudden triggers of 
uncertainty such as recurrence (Mishel et al., 2005) and creating space for hope 
(Babrow, 2001; Frenkel, Ben-Arye, & Cohen, 2010).  
 In addition to cognitive reframing and problem solving, providing informational 
resources can be another way to manage uncertainty (McCormack et al., 2011; Politi & 
Street, 2007).  Information resources are important in the management of uncertainty 
(Davison, Degner & Morgan, 1995; Mishel et al., 2005; Nanton et al., 2009; Neville, 
1998; Schofield et al., 2003; Timmermans et al., 2004).  Under situations of uncertainty, 
it is helpful not only to present information in clear, detailed, and understandable ways 
but also to clarify what is “known” versus “unknown” (e.g., risks and benefits of 
treatment options) (Epstein, Alper & Quill, 2004; Epstein & Street, 2007; Fagerlin, 
Zikmund-Fisher, & Ubel, 2011; McCormack et al., 2011; Schofield et al., 2003).  
 Additionally, presenting information about uncertainty in visual ways can also be 
beneficial (Han, 2013).  Clinicians should provide information based on patients’ 
preferences, and patients should seek information based on their needs (Corbeil et al., 
2009; Mishel et al., 2002).  Important here is short-term uncertainty may often be 
alleviated with information, but long-term uncertainty may require teaching patients how 
to manage their uncertainty by creating time boundaries for how long the uncertainty 
might be tolerated (McCormack et al., 2011).   
Affective Strategies for Managing Uncertainty 
 The second domain involves communicative strategies for managing individuals’ 
affective reactions to uncertainty.  Affective strategies seek to address the emotional side 
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of uncertainty such as anxiety and distress (McCormack et al., 2011).  Though affective 
strategies are less prominent in the literature on managing uncertainty, such strategies 
are still important because the ability to manage uncertainty is connected to patients’ 
emotional states (Epstein & Street, 2007; Han, 2013).   
 One affective strategy to assist individuals in dealing with the negative emotions is 
through acknowledgement and validation (Dean & Street, 2014).  Clinicians should seek 
to recognize the type of uncertainty being displayed and then acknowledge the emotional 
concerns regarding the uncertainty.  To do this, clinicians can engage in techniques such 
as active listening (Razavi & Delvaux, 1997) and asking open-ended questions as they 
provide space for patients to elaborate on their concerns and worries (Street, 1991, 
1992).  Also, acknowledging uncertainty assists in validating the experience of 
uncertainty (Politi, Han, & Col, 2007), which may contribute to a sense of feeling known 
(Anderson et al., 2008; Street et al., 2009).  By acknowledging uncertainty, clinicians 
and patients can come to a shared understanding of whether the uncertainty is reducible 
or irreducible and the reasons or sources of uncertainty (Epstein & Street, 2007; 
McCormack et al., 2011).   
 A second affective strategy is empathy (Dean & Street, 2014).  Empathy is defined 
as the sharing and understanding of individuals’ emotions and thoughts.  Clinicians can 
be empathetic by demonstrating respect, acting as a partner, and providing supportive 
communication messages (Arborelius & Österberg, 1995; Eide et al., 2011).  For 
example, clinicians can inquire about patients’ concerns, demonstrate interest and 
understanding for their circumstances, and build rapport with them (Street, 1991, 1992).  
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A final affective strategy is offering coping resources like counseling services or social 
support groups (McCormack et al., 2011; Mishel et al., 2005).   
Behavioral Strategies for Managing Uncertainty   
 The last domain for managing uncertainty is through behavioral strategies of self-
care or self-management.  Self-management is the perceived ability to self-manage one’s 
illness through navigating the healthcare system, seeking information, coping with side 
effects, and finding help when needed (Bodenheimer, Wagner, & Grumbach, 2002; 
Bodenheimer et al., 2002; Epstein & Street, 2007).  Such management includes both 
tasks that clinicians can perform for their patients, which may eliminate barriers to self-
management, and strategies clinicians can engage in to assist patients in caring for 
themselves (Epstein & Street, 2007).  Specific self-care skills for managing uncertainty 
related to cancer include the following: creating action plans, laying out contingencies, 
journaling, meditating on positive images, and engaging in positive thinking and calming 
self-talk (Mishel et al., 2005; Fatter & Hayes, 2013; Ullrich & Lutgendorf, 2002; Utley 
& Garza, 2011; Wagner et al., 2001).   
 Self-care skills are helpful in managing uncertainty in many different cancer 
stages.  For instance, a cancer patient and her clinician may create a timeframe to assist 
in digesting the multiple treatment options and then come back together to discuss the 
options by a certain date. A cancer survivor and her clinician may construct a back-up 
plan to address if her breast cancer reoccurs; doing so may help manage some of the 
uncertainty about finishing treatment.  Finally, a cancer previvor may engage in personal 
self-care skills such as journaling and mediating to deal with a possible future cancer 
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diagnosis due to a recommendation by her clinician.  
 In summary, managing uncertainty requires patient-centered communication 
between the clinician and patient.  Cognitive, affective, and behavioral communicative 
strategies provide particular ways individuals may manage uncertainty.  Cognitive 
strategies include cognitive reframing, problem solving, and providing information.  
Affective strategies encompass acknowledging and validating emotions, being 
empathetic and actively listening, and offering resources for coping.  Lastly, behavioral 
strategies involve self-management skills such as creating action plans and meditating on 
positive images.  However, despite these different strategies for managing uncertainty in 
cancer, much still needs to be learned about what particular strategies work for particular 
people.  More specifically, there is a need to explore how particular people experience 
uncertainty and what strategies help them cope.  
Research Questions 
Thus, the goal of my dissertation is to describe, understand, and interpret 
previvors’ health experiences regarding patient-centered communication especially as it 
relates to managing uncertainty.  As such, this dissertation is guided by two main 
research questions:  
(1) What are the sources of uncertainty for previvors, and what types of strategies 
do previvors employ to manage their uncertainty in clinical encounters?  
(2) How do previvors’ uncertainties influence their health decisions in clinical 
encounters?  
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Now that I have reviewed relevant literature, I discuss the methods I engaged in to 
answer my research questions.  
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CHAPTER II  
RESEARCH METHODOLOGY 
 
“My daughter doesn’t dwell on cancer, but I’ve heard her say, “It’s not if I get cancer, 
it’s when I get cancer.” She uses this phrase because she says it will help her, IF she 
gets cancer, to move forward quickly and positively. But, that’s a burden for a mother; 
one our family lives with.” 
 ~ Deborah Olson-Dean 
My mom is right.  I still feel the effects of those early years.  I hate hospitals.  I 
hate blood.  Needles.  Doctors.  The antiseptic smell.  And, above all, I hate the sight of 
sick people with their families surrounding them, watching as their loved ones’ lives 
wither away.  As the daughter of a 17-years old breast cancer survivor, I have always 
been interested in health communication.  From a young age I watched my mother 
undergo breast cancer surgery, chemotherapy, hair loss, nausea, radiation, and 
reconstruction.  Though scared, I was determined to be involved, as much as an eight 
year old could be.  Now, as a previvor myself (BRCA2+), I am realizing just how much 
breast cancer rages through my family, and it is my passion for this topic that drives my 
research.  Thus, in this section, I describe my research methods for this dissertation, 
highlighting my role as a researcher, the justification of qualitative methods, and data 
collection and data analysis. 
My mother was diagnosed with breast cancer in 1997.  One month earlier than 
my mom, my grandmother was diagnosed.  Two years following, my Aunt, my mother’s 
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younger sister, was diagnosed.  Since then both have tested positive for the BRCA2 
gene. Later my other Aunt, my mother’s oldest sister (the sister who has not fought 
breast cancer), researched and found out that my paternal great-grandma died of breast 
cancer at 35 years old, and my grandma’s sister died after living with the disease for 20 
years.  Since then, my Aunt, on my dad’s side, has been diagnosed (see Figure 1 for our 
family tree).  For my family, breast cancer is not just a disease.  For so long breast 
cancer has seemed to define how we live our lives. 
 
 
Figure 1. My Family Health Tree 
 
 
 
More recently, however, breast cancer is affecting my family and me in a 
different way.  Instead of coping with family members who have had breast cancer and 
the associated perils, I now have to think about the future of my own immediate family.  
Since I found out I have the BRCA2 gene mutation, my husband and I have been 
discussing what our family plans might look like now.  I always saw children in my 
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future, but in all honesty, I never thought much about the details.  Now, I am being 
forced to do so.  Do I risk possibly passing the mutated gene to a daughter, a son?  When 
do we try to start having a family?  Do I speed up my timeline in order to have children 
before having a prophylactic mastectomy and eventually an oophorectomy and 
hysterectomy?  These are just a few questions that have been whirling around inside my 
head.  
Given my own experiences and personal interest in this dissertation, I am aware 
that being a BRCA2 previvor will influence not only my conversations with my research 
participants but also my analysis of those interactions.  I share this information in the 
spirit of self-reflexivity—constantly assessing how the researcher is affecting and 
influencing both the collection and analysis of data (Hesse-Biber & Leavy, 2006).  Self-
reflexivity is especially important in qualitative research because the researcher is the 
primary instrument for collecting and analyzing the data (Merriam, 2009).  Furthermore, 
Lindlof and Taylor (2011) state reflexivity involves critical reflection about how the 
researcher, her participants, and the phenomena of interest influence and interact with 
each other.  Thus, engaging in self-reflexivity will be important throughout my 
dissertation but especially qualitative data collection and analysis.  
Justification for Qualitative Methods  
Research inquiry should always direct the research method.  So, in light of my 
research goals, qualitative research methods are most appropriate.  I am interested in 
describing, understanding, and interpreting previvors’ lived experiences, perceptions, 
and social constructions of life.  Qualitative methods provide a way to understand how 
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individuals construct their world and the meanings they associate with such experiences 
(Hesse-Biber & Leavy, 2006; Lindlof & Taylor, 2011; Merriam, 2009).  In addition, 
qualitative research recognizes specific patterns of multiple realities (Steubert & 
Carpenter, 1999).  Interviewing previvors with different health experiences and 
decisions allowed me to identify certain pathways through which previvors construct 
their realities.  Finally, qualitative methods in health communication can assist in 
understanding processes regarding healthcare (Britten, 2011).  Therefore, qualitative 
methods enabled me to learn about the previvor community and possibly different 
pathways of coping with uncertainty and emotional distress (Lindlof, 1995).  
Data Collection  
After receiving Institutional Review Board approval and informed consent from 
my participants, I conducted semi-structured interviews with previvors.  An interview is 
defined as “a process in which a researcher and a participant engage in a conversation 
focused on questions related to a research study” (deMarrais, 2004, p. 55).  A researcher 
engages in this method of interviewing when she cannot observe participants’ behaviors, 
feelings, or interpretations of their worldview and when the researcher is interested in 
past events that cannot be replicated (Hesse-Biber & Leavy, 2006).  Hence, it is through 
the dialogue or conversation between the interviewer and the interviewee that knowledge 
is produced and understood (Kvale, 1996).  
Moreover, semi-structured interviews employ a predetermined list of issues and 
questions to guide the conversation, while also providing latitude to add information 
during the interviews (see Appendix A for my interview questions) (Merriam, 2009).  
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This style of open-ended interviewing enables the researcher to explore individuals’ 
views and realities of life and ultimately generate theory (Reinharz, 1992).  Additionally, 
semi-structured interviews create a more natural conversation between the interviewer 
and interviewee.  So this type of interviewing is appropriate to learn about previvors’ 
health experiences because it facilitates in-depth understanding and cultivates a 
comfortable environment for the participants (Lindlof & Taylor, 2011).  In short, semi-
structured interviewing enabled me to guide the interview conversation while also giving 
some control to the participants (Fontana & Frey, 1994).  
Research Participants  
Because the data for this dissertation draws upon previvors’ health stories about 
managing their uncertainty, I interviewed 34 female previvors.  The sample size is 
appropriate because the purpose of my research is to look at the “process” or “meaning” 
individuals attribute to their social situation (Hesse-Biber & Leavy, 2006, p. 70), not to 
generalize experience to all previvors.  
There were two important criteria for identifying participants.  First, the 
participants were women and, second, the women must have tested positive for either the 
BRCA1 or BRCA2 gene mutation. In addition to these two criteria, I originally desired 
the participants’ preventative health decisions to vary because I wanted to understand the 
different ways previvors manage their uncertainty about their high risk for breast and 
ovarian cancer.  For example, dominant categories of prevention for positive BRCA 
gene carriers include prophylactic surgeries (e.g., mastectomy, oophorectomy, 
hysterectomy), chemoprevention (e.g., drug tamoxifen), and increased detection (e.g., 
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mammograms and MRIs and ultrasounds and CA125 tests every 6 months) (see 
Appendix B for a list of technical terms).  The rationale for having women who had 
engaged in different health decisions is based on the idea that individuals respond in 
different ways to uncertainties in life.  Yet even though I pre-screened the participants 
before conducting the interviews, the majority of women who were interested in 
interviewing with me had chosen preventative surgeries.  To protect the participants, 
pseudonyms are used throughout the dissertation.  
Participants’ Demographics 
The majority of women interviewed were Caucasian (e.g., 26 total).  Yet in 
addition, one woman identified as Chinese; another identified as Ashkenazi Jewish; 
another identified as Caucasian and Colombian; another identified as Caucasian and 
Hispanic; and four women identified as Caucasian and Ashkenazi Jewish.   
As for age, the majority of women were between 30-39 years old (e.g., 21 total).  
Additionally, six women were between 40-49 years old.  Two were between 20-29 years 
old.  Three women were between 50-59 years old, and finally two were between 60-69 
years old.   
Finally, 17 of the women have the BRCA1 gene mutation, and 17 of the women 
have the BRCA2 gene mutation.  Also, 26 of my participants had undergone a 
preventative double mastectomy.  13 participants had undergone a preventative 
oopherectomy, hysterectomy, and sometimes both.  Lastly, four participants are 
currently engaging in increased surveillance, and one woman is undergoing 
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chemoprevention (see Appendix C for the specific breakdown of the participants’ 
demographics).  
Recruitment 
I recruited my participants through Facing Our Risk of Cancer Empowered’s  
(FORCE) social media pages (e.g., message boards, Facebook, Pinterest).  Sue 
Friedman, a former veterinarian and breast cancer survivor, founded this online, non-
profit organization FORCE in 1999 under the belief that no one should go through 
hereditary cancer alone.  Therefore, FORCE is committed to improving previvors and 
families’ lives that are affected by hereditary breast and ovarian cancer.  
I chose to recruit my participants from this organization for two main reasons—
their important presence in the previvor community and their commitment to advancing 
research on hereditary cancer.  First, FORCE coined the term “previvor” in 2000 when a 
community member stated she “needed a label.”  As previously discussed, the term 
previvor refers to individuals who are highly predisposed to breast and ovarian cancer 
due to a genetic mutation and thus have different needs and concerns regarding cancer 
than the general population.  Since 2000, the organization has been instrumental in 
educating individuals about advancements in cancer detection, treatment, and quality-of-
life issues but most importantly cancer prevention.  For instance, according to their 
website, FORCE has the following eight main mission objectives:  
• To provide women with resources to determine whether they are at high risk for 
breast and ovarian cancer due to genetic predisposition, family history, and other 
factors.  
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• To provide information about options for managing and living with these risk 
factors.  
• To provide support for women as they pursue these options.  
• To provide support for families facing these risks.  
• To raise awareness of hereditary breast and ovarian cancer.  
• To represent the concerns and interests of our high-risk constituency to the 
cancer advocacy community, the scientific and medical community, the 
legislative community, and the general public.  
• To promote research specific to hereditary cancer.  
• To reduce disparities among underserved populations by promoting access to 
information, resources, and clinical trials specific to hereditary breast and ovarian 
cancer (“Mission,” par. 2).  
These objectives demonstrate FORCE’s importance to the previvor community but also 
their commitment to research, which is discussed next.  
The second reason I chose FORCE as the organization to recruit the participants 
is their commitment to research on hereditary cancer.  According to their website:  
FORCE recognizes the importance of collaboration between health care 
professionals, researchers, and lay advocacy groups, particularly regarding a rare 
disorder such as hereditary breast and ovarian cancer syndrome. We are 
committed to working together to assure the high-risk community and general 
populations receive up-to-date, credible information on hereditary breast and 
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ovarian cancer risk and management, and have access to the latest research and 
the best care” (“Information for Researchers,” par. 1). 
Thus by recruiting through FORCE, I positioned my research and myself in a visible 
way, but more importantly, among individuals who are passionate about assisting others 
like themselves.   
It is important to note that in exchange for recruitment advertising through 
FORCE’s social network, the staff encourages researchers to fund their own research 
costs such as outreach, consulting, advertising, or travel expenses.  Furthermore, they 
also request an acknowledgement of their contribution to the research in any publication 
or presentation.  I have adhered to both requests.   
Data Analysis  
After recruiting previvors willing to participate in this dissertation, I conducted 
semi-structured interviews to explore my specific research interests.  To answer my 
research questions, I recorded and transcribed the interviews into a Word document.  
Then I used the constant comparison method to code my data (Glaser & Strauss, 1967; 
Lindlof & Taylor, 2011).  I chose this method of analysis because it is considered the 
most prevalent and widely accepted way to code qualitative data (Glaser & Strauss, 
1967; Lindlof & Taylor, 2002; Strauss & Corbin, 1990, 1994).  To analyze my data, I 
engaged in open coding by sorting and tagging the data into themes.  In other words, 
first, I categorized the data (Strauss, 1987). Second, I employed axial coding to refine 
the codes by grouping and relating the codes to each other (Corbin & Strauss, 2007).  
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Also, I wrote reflective memos throughout the study to record possible themes and notes 
(Glaser & Strauss, 1967). 
The themes within the interview transcripts served as the units of analysis.  A 
theme represents a cognitive schema set that can be used to conceptualize and 
understand ideas and relationships (Owen, 1984).  Themes were detected based on 
Owen’s (1984) three criteria—recurrence, repetition, and forcefulness.  Recurrence 
refers to when there are at least two mentions of a general idea with the same meaning 
regardless of the words used.  Repetition refers to repeated words, phrases, and 
sometimes sentences.  The last criterion is forcefulness, which refers to the participants’ 
vocalics (e.g., inflection, volume, pauses, etc.) that emphasize certain utterances as well 
as stress written phrases or words (e.g., underlining, italics, increased print, etc.). 
Finally, I engaged in two strategies for increasing the credibility, transferability, 
and consistency of my research findings (Lindlof & Taylor, 2011).  First, I wrote 
reflexivity journals.  A reflexive journal is a helpful research tool because it allows the 
researcher to record key information about the study such as schedules, methodological 
decisions, questions of ethics, initial analyses, and other important decisions and notes 
for the study (Lincoln & Guba, 1985).  Furthermore, a reflexive journal serves as an 
audit trail for data analysis to enhance transferability of my research (Lindlof & Taylor, 
2011) as well as a place for researcher self-reflexivity.   
Second, after completing my data collection and analysis, I conducted member 
checks with a sample of participants.  I conducted member checks for two reasons.  
First, I wanted to ensure the participants are comfortable with the manner in which their 
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perspective was being portrayed in my analysis (Lindlof & Taylor, 2011), and second, I 
also wanted to determine if my participants felt the findings resonate with their lived 
experiences and thus provide communicative validity to my study (Hesse-Biber & 
Leavy, 2006).  The member check process varied per participant.  The majority of 
participants simply requested a summary of the findings to determine if they resonated 
with their experiences, while one participant wanted to review her whole interview 
transcription.  Participants did indicate the findings accurately represented their health 
experiences.  
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CHAPTER III  
FINDINGS 
 
Research Question 1 
Research question one asked what are the sources of uncertainty for previvors, 
and what types of strategies do previvors employ to manage their uncertainty in clinical 
encounters. Analysis revealed two main uncertainty sources for previvors—medical 
uncertainty and familial uncertainty.  Medical uncertainty types include the unknown 
future, peaks and valleys associated with medical consultations, and personal cancer 
scares.  Familial uncertainty encompasses traumatic family cancer experiences and being 
a mother and being present in children’s lives.  I first discuss the sources of medical 
uncertainty.  
Medical Uncertainty  
“The Unknown Future”   
The first type of medical uncertainty for previvors is “the unknown future.”  
Broadly, previvors grapple with an uncertain future.  From deciding whether or not to 
undergo genetic testing to making health decisions after testing positive for the BRCA 
gene, previvors are uncertain, anxious, and fearful about what their future may bring.  A 
common inter-dialogue for a previvor is: “Well, today I’m fine, but what about the 
future? What about my next mammogram or ultrasound?”  In other words, previvors feel 
like knowing that they are at high risk is simply an “endless waiting game” for your 
“ticking time bomb boobs to go off.”   
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Jacklynn, a 34-year-old, Caucasian and Colombian BRCA1 previvor described 
what it means to have an unknown future.   
As soon as I got the results of the BRCA test, I really felt like I went through the 
stages of grief—denial, being upset, being mad—and then once all of that passed, 
I started doing research and doing surveillance, but then after that first MRI, and 
the clinicians saying, ‘We think we see something.’ And then having the second 
[test], which didn’t confirm anything, I just felt like this ticking time bomb. 
When am I going to get cancer? Some people can live with that, and it’s fine. But 
I’ve just been always an anxious person, so if I can just take care of something, I 
want to take care of it. And also talking to the doctor, he made me more aware 
that it’s not just an increased risk that I have, and then I was thinking about how 
young my aunt and uncle were when they died…Some people are wired to deal 
with it better, but I’ve never been good at that.  
As exemplified here, first, Jacklynn illustrates her experience trying to deal with testing 
positive for the BRCA gene and the consequences it had on her future.  Originally, she 
wanted to reduce her uncertainty about whether or not she had the gene, but after testing 
positive, she realized she now had to cope with a very high cancer risk.  Said differently, 
testing positive led Jacklynn to experience uncertainty about a possible cancer diagnosis 
and fear about what the future might bring, which produced severe anxiety and distress.  
In addition to the fear of a cancer diagnosis, previvors are also uncertain about 
when they might develop the cancer during their lifetime.  Previvors hold the belief “it’s 
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not if I get cancer, it’s when.”  Tara, a 28-year-old, Caucasian BRCA2 previvor 
explained this struggle:  
You know the unknown is simply too much to handle…It is like, since I do have 
a strong family history [of cancer], and I do have the gene, to me it was like 
when is the cancer going to start. Is the cancer going to start? And the unknown 
of when it will start and if it will start…I mean it’s not like I have a crystal ball to 
figure it out, you know. There’s no way to know if I [will get] cancer or not, even 
though I have a strong family history, but it was just the unknown of not 
knowing, if I would get it or when I would get it. Will it be phase three [cancer] 
or phase one? I meant it was stuff like that. The unknown of not knowing and not 
having a crystal ball to determine when it might be was just too much. 
Like Jacklynn, after testing positive for the BRCA gene, Tara struggled with when the 
cancer would manifest in her body like it did with her female family members.  Thus, 
she constantly worried about if cancer was growing and how severe it would be when it 
was discovered.  
Interestingly, it is not just previvors who hold this viewpoint about the unknown 
future.  Savannah, a 31-year-old, Caucasian BRCA2 previvor reiterated a crucial 
interaction she had with a physician which increased her uncertainty about when she 
would develop cancer during her lifetime.  She stated:   
My biggest fear in life was always that I would get cancer…and my chances of 
getting cancer were just too high to deal with. I mean I was walking around with 
a 95% chance [of developing breast cancer], and after I tested positive for 
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BRCA2, I was talking to my gynecologist about options for dealing with this 
high risk such as increased surveillance versus a preventative double 
mastectomy, and my doctor said that, ‘It’s not really a matter of if I would get 
cancer, but when,’ and when she said that, I said ‘OK, what [breast] surgeon do I 
go see because it is time [to do a mastectomy].’ 
So for many other previvors as well as some clinicians uncertainty about the future can 
be too much to handle.  As such, it is clear one overarching medical uncertainty source 
for previvors is the unknown future—not if they might get cancer but when.  
“Peaks and Valleys”   
The second source of medical uncertainty relates to medical consultations.  
Previvors explain they do not experience uncertainty all day, every day, but instead, such 
emotions and worries surface with their medical consultations.  Previvors depict the 
“peaks and valleys” or “ups and downs” that occur every six months when they go in for 
their biyearly consultations.  A biyearly consultation typically involves a mammogram 
and/or a MRI to check the breasts and a transvaginal ultrasound and a CA125 test to 
check the ovaries.  Many previvors do not dwell on a possible suspicious spot or a lump 
for months at a time, but then the days leading up to their appointment they begin to 
experience significant, overwhelming fear and anxiety about what their physicians might 
be find.   
Jennifer, a 30-year-old, Caucasian BRCA2 previvor, demonstrates this type of 
medical uncertainty as she depicted a recent medical consultation experience.  
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It comes and goes in peaks and valleys. I will get these waves of emotions, and it 
is not related to my cycle, but it is every three to six months, and all of a sudden 
something will trigger…Because of [buying a new] house, we decided to wait on 
my surgery, and the part that I started to get anxious about was that I realized that 
because I was not having my surgeries, now it has been six months since my last 
round of surveillance, and so I have to go through another round of testing…Like 
I have to go through the blood test for the CA125. I haven’t even gone into see 
my breast doctor for an office exam, but I have to get that taken care of, and I 
need to go see my gynecologist who is going to set up the ultrasound, and I have 
to follow-up on the mass in my breast, and so that gave me a whole new…I think 
it was just because it was so fresh; I realized that I was going to have to go 
through this all of again, and ‘Oh my gosh,’ what if they find something and it 
ends up being nothing, but I end up going through that fear again of what if. It is 
almost like every six months or every year you are simply just waiting to find out 
if you have cancer. That in and of itself is very stressful, and it takes a major 
emotional toil…Every time I have to come back and do one more wave of 
surveillance and tests, it’s just more emotions. 
Here, Jennifer provides a window into understanding uncertainty’s emotional 
rollercoaster.  Because she was not able to undergo the preventative surgeries due to her 
family’s relocation, she experienced uncertainty and emotions again, feelings she 
thought she had left behind after deciding to have the preventative surgeries.   
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Samantha, a 35-year-old, Caucasian BRCA2 previvor, also understands this type 
of medical uncertainty.  During a medical consultation after she turned 35, her breast 
surgeon informed her they now had to do surveillance every six months (e.g., rotating 
back and forth between mammograms and MRIs) to make sure cancer was not 
developing.  Upon hearing this news, she shouted to her physician, “No! I don’t want to 
do that. I don’t want to go through those six months up and down.” 
Likewise, Madison, a 32-year-old, Caucasian BRCA1 previvor, shared a similar 
perspective:   
Getting mammograms and MRIs, I would just get stressed out before each one, 
so it was just a stress I didn’t want to deal with. I would wonder is this was the 
day that they would find the cancer. I would just get really stressed out before 
each one, and I would wonder if this was my last day of ignorance, and I would 
just get really worried every six months. 
Bailey (33-year-old, Caucasian BRCA1 previvor) expanded on this concern, 
discussing how this medical uncertainty type relates to making health decisions.  She 
said,  
My fear with surveillance was that just because you are being screened every six 
months doesn’t mean that you aren’t going to get cancer, and I just, well you are 
hopeful that [the clinicians] pick it up earlier than they would have otherwise. 
And I am kind of a worrier, and I think I would have been worried in the weeks 
leading up to the appointment, and then once I had the appointment, it is a day 
off of work, or a half of a day, and then you have to drive back and forth to the 
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hospitals and the centers to have the screening done, and then it’s another day or 
week before you get the results, and so is that really worth dealing with every six 
months? And at what point and at what age in my life am I going to get the 
phone call that I need to come back in for a biopsy, or they think that they see 
something? So I made my decision that I was not going to deal with that.   
So not only is it being uncertain about one’s future, but also a previvor’s uncertainty is 
heightened at each medical consultation.  As such, because of this medical uncertainty 
type, which occurs approximately every six months, many previvors, like Jennifer, 
Samantha, Madison, and Bailey, decide to undergo preventative surgeries.  Previvors see 
surgery as a way to manage the uncertainty at each medical consultation, which is 
discussed in research question two.    
“Cancer Scares”   
The third source of medical uncertainty for previvors is personal scares of a 
possible cancer diagnosis.  Many previvors described after they tested positive for the 
BRCA gene, they engaged in increased surveillance, but then during a mammogram or 
MRI screening test, a physician found a “suspicious lump” or “dark spot” in a breast.  
Identifying this possible cancerous lump or spot also heightened previvors’ uncertainty 
about their unknown future.   
Camille, a 47-year-old, Caucasian and Ashkenazi Jewish BRCA2 previvor, 
described a personal experience where she had to confront a possible cancer threat and 
how the experience increased her medical uncertainty.  
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In 2012, in early in May, [the doctors] saw something, and so I had to do the 
whole needle biopsy guided by an MRI, which is very painful and very, very 
stressful while you are waiting for those results. And so that was really the ‘icing 
on the cake’ for me…So I just decided that [the doctors] are always going to see 
something. Luckily, [the results] came back negative, but just with my dense 
breast tissue and with my heightened surveillance, you know, how many biopsies 
can you have [before they discover something cancerous]? 
However, this medical uncertainty type is not only rooted in a possible cancerous 
spot found during clinical surveillance but also during personal surveillance.  Nancy, a 
40-year-old, Caucasian BRCA2 previvor, explained how she has always worried about 
missing something while performing her own self-breast exams.  She said, “So basically, 
it was just, you know, a fear or worry in the back of my mind that I’m not catching 
something, or even if there’s something little that I can’t feel.”  Now, much of this worry 
originated because Nancy’s sister’s cancerous lump grew rapidly, but the fear of missing 
a lump was constantly in Nancy’s mind.  
Much like Nancy’s experience, for many previvors, finding a possible cancerous 
lump or spot solidified their high genetic cancer risk and made their unknown future 
finally feel “real.”  Before, possibly being diagnosed with cancer seemed in the future, 
but when a physician identified something that could be cancerous, the women “freaked 
out.”  For instance, during one clinical consultation, Madeline’s (a 38-year-old, 
Caucasian BRCA2) clinician found eight suspicious lumps!  She exclaimed,   
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At the time that I tested positive, [the doctors] had also done breast MRIs on me, 
and they found eight [spots] that they thought were very suspicious. And so they 
wanted to test some of those spots, and I had two small children at home, and this 
diagnosis, and then I had all of these suspicious spots! So I felt a lot of anxiety, 
fear, really thinking about the journey that my mother took, and really just 
hoping that that didn’t play out for my children to watch. It was a lot of stress at 
the time. But luckily, the spots came out clean, well three came out clean, but 
there were five more that they wanted to get a good look at, but it was at that 
point that I just decided, you know what, I know I have this gene, and I’m done 
having children, and I have all of these spots, so I decided to just go ahead and do 
a double mastectomy…The spots that I was having, I just couldn’t handle going 
through the testing for those spots and then waiting for the results and worrying 
about it.  
Similarly, Maria, a 30-year-old, Caucasian BRCA2 previvor, expressed the 
medical uncertainty she felt when her doctors found a lump in a breast after she gave 
birth to her second son.  The breast surgeon recommended waiting six months to 
determine if the lump was indeed “something.”  But Maria emphasized she could not 
play the “waiting game” because she was going “crazy.”  She hated how she knew there 
was something “suspicious” in her body, but she could not see it or do anything about it.  
Thus, even though these lumps often turn out to be non-cancerous, the personal cancer 
scares influence previvors’ health decisions such as deciding to undergo a preventative 
double mastectomy.   
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In sum, previvors first source of uncertainty is medical.  Medical uncertainty 
includes the following types: the unknown future, peaks and valleys associated with 
medical consultations, and personal cancer scares.  Yet as seen above in some previvors’ 
responses, family is also a source of uncertainty.  I now expound on this source.  
Familial Uncertainty 
“I Don’t Want to Be My Mom.”   
The second main source of uncertainty is familial uncertainty.  Under familial 
uncertainty, the first type is previvors’ traumatic family experiences with cancer.  
Previvors illustrated how cancer infiltrated their extensive family trees with diagnoses 
and deaths.  The significant past experiences typically related to their mothers, but also 
sometimes, previvors would talk about other family members’ experiences (e.g., sisters, 
aunts, grandmothers, and cousins).   
Veronica, a 38-year-old, Caucasian BRCA2 previvor, described her family’s past 
experience with cancer as a source of familial uncertainty.  
Because my siblings and I were so young when my mother died, it was such a 
traumatic thing for our family, and you know, I had a stepmom that did her best, 
but it’s not the same as having your own mother...Anyway, I’ve got 3 kids. At 
the time of my [preventative mastectomy] surgery, my eldest had just turned 7, 
and then I had a 1 and 3-year-old. So it was very personal for me in that having 
many children. I didn’t want them to go through what I went through. 
Veronica’s past experience mirrors many previvors’ experiences.  Previvors discussed 
how they spent countless hours in hospitals and doctors’ offices and watched their loved 
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ones undergo endless surgeries, radiation, chemotherapy, nausea, and vomiting.  These 
past experiences forever imprinted their lives with cancer fears.  As such, testing positive 
for the BRCA gene is extremely difficult since it triggers previvors’ past memories with 
family members who fought cancer.  
Moreover, previvors emphasized they do not want to be their mothers and go 
through what their mothers did.  Savannah, a 31-year-old, Caucasian BRCA1 previvor, 
said,  
I love my mom, but I don’t want to end up like her…I don’t know how my mom 
is alive; she’s battled cancer six times, and it’s amazing she is walking around 
today, but I’ve had to take care of her at a very early age for nearly 15 years, and 
I don’t want my kids to have to do, even though I know they would, and do it 
proudly… 
Likewise, Lacy, a 51-year-old, Caucasian BRCA2 previvor, discussed how her 
memories with her mother’s cancer affected her experiences.  Lacy’s mother was 
diagnosed with breast cancer at 69-years-old and then was diagnosed with Stage IIIC 
ovarian cancer at 74-years-old.  Lacy’s experiences were difficult and emotional because 
not only was Lacy dealing with her own positive tests results, but also she put all of her 
time and energy into helping her mom fight her cancer.  She explained, “Having 
watched my mom have ovarian cancer, you know, obviously I’m not looking forward to 
doing that [oopherectomy] surgery, but I am highly motivated to not get ovarian cancer.”  
So in different ways and at different life stages, both Savannah and Lacy had to take care 
of their mothers, which left a lasting impact on their own health.  
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Lastly, other previvors noted their uncertainty and anxiety is related to attending 
medical consultations that trigger past memories such as being in hospitals and caring 
for loved ones.  For instance, Addison, a 33-year-old, Caucasian BRCA1 previvor, 
described how traumatic her first surveillance appointment was after she tested positive 
for BRCA.  While sitting in the waiting room for her appointment, Addison “busted into 
tears” because she was next to old cancer patients who reminded her of her mother.  She 
exclaimed:  
There you are sitting having known what your mother had gone through, and I 
mean I knew what cancer had done to her body and the damage. I saw how 
strong she was, and I just, you know, I was in the waiting room with women who 
had Stage III cancer and next to older women, and here I was healthy and 25, 
and they were just looking at me weird…I just felt angry. 
Addison’s past memories with her mom overwhelmed her in that moment.  She felt 
alone, scared, and like she did not belong.  In the waiting room, Addison experienced 
intense feelings of fear and uncertainty, which solidified what it truly meant to test 
positive for the BRCA1 genetic mutation.  Thus, traumatic family cancer experiences are 
a type of familial uncertainty for previvors.  
“What About My Babies?!”   
The second type of familial uncertainty, and the final uncertainty source for 
previvors, is the importance of motherhood and being present for children’s lives.  For 
some previvors, the first type originated from the fear of being diagnosed with cancer, 
dying, and then leaving their children behind.  In this way, it also relates to the previous 
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uncertainty source—traumatic family experiences with cancer—and not wanting their 
own children to grow up without a mother.  Previvors shared the belief they did not want 
their children to ever see them sick or struggle with cancer and certainly did not want 
their children to see them die.   
For example, Bailey (a 33-year-old, Caucasian BRCA1 previvor) described her 
concerns about her children:  
My fear was that as my kids would get older, and they would remember more 
and more about my sickness or struggles or battles that I went through, and with 
being so young, this quick recovery hasn’t been so bad [referring to the recovery 
after her preventative mastectomy], but what if I was sick for years and years? I 
don’t want that to be burned into their memories—that for ten years Mom was 
sick. Or for ten years Mom couldn’t make baseball games or go take me to 
school or do this or do that.  
However, this worry of developing cancer and not being present for children’s lives was 
also framed in positive ways.  Camille, a 47-year-old, Caucasian and Ashkenazi Jewish 
BRCA2 explained, “I have an amazing child who is going to get married and have 
babies one day, and I have to be there for that.”  So this uncertainty type is connected to 
previvors’ role as a mother.   
Finally, because of familial uncertainties, previvors make particular health 
decisions.  For instance, Savannah’s (a 31-year-old, Caucasian BRCA1) decision 
represents many previvors’ decisions.  She chose a preventative double mastectomy, 
hysterectomy, and oophorectomy because she believed the surgeries would provide her 
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with the greatest chance to watch her kids grow up and take care of them.  In short, not 
getting sick and being present in children’s lives is essential for previvor mothers.  
Summary   
In sum, there are two main sources of uncertainty for previvors—medical and 
familial uncertainty.  First, an unknown future is a medical uncertainty type because 
previvors never know when their high cancer risk might actually manifest in their 
bodies.  Also, the time leading up to medical surveillance appointments invokes 
uncertainty about if a cancerous spot or lump will be found.  Moreover, personal cancer 
scares create uncertainty as previvors anxiously wait for test results to determine if 
cancer is present or not.  In fact, such personal scares often remind previvors of the 
traumatic family memories they experienced in the past, which only reinforces their 
uncertain future.  Lastly, being a mother and being present in children’s lives is a final 
uncertainty source because previvors do not want their children to experience what they 
went through with their own mothers and relatives.  
Uncertainty Management Strategies  
Because previvors experience uncertainty in clinical encounters, the second part 
of research question one asked what types of strategies do previvors employ to manage 
their uncertainty in clinical encounters.  Analysis revealed the following four main 
strategies: 1) seeking clinicians as an informational source, 2) seeking clinicians as a 
partner for decision-making, 3) seeking clinicians as an emotional support, and 4) 
seeking referrals from clinicians for emotional support.  I first discuss the most common 
uncertainty management strategy—seeking clinicians as an informational source.  
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Seeking Clinicians as an Informational Source   
The first uncertainty management strategy previvors engage in is seeking 
clinicians as an informational source.  Because previvors are uncertain about the 
unknown future, experience peaks and valleys, worry about personal cancer scares, 
reflect on past family experiences, and fear leaving their children behind, information 
and knowledge is seen as an effective way to manage those uncertainties.   
First, previvors placed a significant emphasis on clinicians’ expertise and 
knowledge regarding BRCA patients, research, treatments, and experiences.  For 
example, Tara, a 28-year-old, Caucasian BRCA2 previvor, explained the extreme 
difference in knowledge between her clinicians in Los Angeles who specialize in BRCA 
and her clinicians in San Antonio who are general gynecologists.  
My doctors in San Antonio don’t know as much about the BRCA gene as my 
doctors in LA did. Like there aren’t many people in my practice in San Antonio 
that have the gene, and so [the clinicians] don’t really know how to properly 
communicate the steps of what you need to do next…When I lived in LA, I had a 
gyn-onco [gynecologist oncologist] as my OBGYN who specifically dealt with 
cancer. But when I moved back to Texas, and I went back to my old OBGYN, he 
who doesn’t really deal with cancer a lot. I haven’t found a gyn-onco that I like, 
and so it’s like they don’t really know how to deal with the whole BRCA gene, 
what the patients have to go through, and so I am teaching the doctors about it in 
a way…I am having to be my own self-advocate about my health. And it’s 
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exhausting to have to keep teaching people that this is what the gene is and this is 
how you should be treating me.  
 Likewise, Jennifer (a 30-year-old, Caucasian previvor) portrayed her experience 
visiting her OBGYN after testing positive for BRCA2 and declared how frustrated she 
was about her gynecologist’s lack of knowledge about BRCA.  She said,  
I went to my gynecologist, and when I told him that I had been positive for 
BRCA2, his response – not to the exact words – it was ‘Oh, so you have both 
BRCAs?’ And I went ‘Ah, no!’ You don’t know what you’re talking about. And 
that really made me immediately uncomfortable because I thought, am I in the 
wrong place? He’s a great OB, but I could tell he was not the gynecological 
specialist in the office…I felt like I was educating my physicians.  
In both Tara and Jennifer’s cases, their clinicians’ lack of BRCA knowledge and 
expertise produced immense frustration and caused them to have to educate their own 
physicians, which only increased their uncertainties.  
So interacting with clinicians who are knowledgeable about BRCA related issues 
is important because otherwise previvors worry more about their unknown future.  Lacy, 
a 51-year-old, Caucasian BRCA2 previvor, discussed how after testing positive, she 
wanted to get involved in a high risk center that specialized in BRCA patients because 
she did not want to have to worry about their expertise.  As such, Lacy joined a high-risk 
surveillance program at Stanford.  Since then she has greatly enjoyed not having to 
explain things about BRCA to her physicians because they know what is expected, 
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appropriate, and important. Because as Tiffany (a 38-year-old, Caucasian BRCA1 
previvor) said, “It is doctor’s ignorance that is killing people.”   
In addition then to being “well-versed in BRCA” as Rebecca (a 44-year-old, 
Caucasian BRCA2 previvor) pointed out, previvors are better able to manage their 
uncertainties if they are able to discuss all relevant information about what it means to be 
BRCA+ and the different health decisions.  Hence, it is not enough to be knowledgeable 
about BRCA, previvors also seek clinicians who can provide and discuss BRCA 
information, ranging from topics such as receiving genetic test results to making 
decisions about preventative surgeries.   
For example, Nancy, a 40-year-old, Caucasian BRCA2 previvor, emphasized 
what helped her feel better about her unknown future after she received her tests results 
was a detailed conversation with her genetic counselor.  The counselor spent a long time 
talking about the results and what the results meant for her and her family’s lives.  She 
explained:  
Our genetic counselor, she was amazing. I mean she was a wealth of 
information! When we got our test results, my mom and my sisters and I all went 
together to get our results together, and she spent probably an hour with us 
afterwards talking about, you know, what our next steps were and things we 
needed to be doing, and what doctors we needed to be seeing. It was just so, so 
helpful. 
 Likewise, when shopping for a plastic surgeon, Jacklynn (a 34-year-old, 
Caucasian and Colombian BRCA1 previvor) stated the plastic surgeon she picked, “He 
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answered so many of my questions, and I felt like I was going to drive him crazy, and 
that he might refuse to treat me because I had so many questions.”  But by answering her 
many questions, Jacklynn felt better about her decision.  
 Yet it was not just the provided information that allowed Jacklynn to manage her 
uncertainty but also the manner in which the information was provided.  In addition to 
providing information, clinicians need to make sure their patients understand the 
information.  For instance, Sophia, a 33-year-old, Chinese BRCA2 previvor highlighted 
how her genetic counselor not only provided her with information but also made sure 
she understood the information before leaving the consultation.  Also, Sophia’s nurse 
practitioner in charge of her case was helpful because she talked about everything—from 
testing positive to increased surveillance to surgeries and made sure Sophia understood 
all the information.   
 Also, previvors stressed information must be provided in laymen’s terms in order 
to help them manage their worries and anxieties.  Janet, a 51-year-old, Caucasian, 
BRCA1 previvor, explained her clinicians at MD Anderson were excellent 
communicators due to their ability to speak in terms she could understand.  She asserted,  
An excellent communicator is someone who can explain things in terms that I 
would understand. Medical person to medical person you can use all of the 
jargon that you want, but medical person to patient bring it down to my level. 
And I think all of the doctors at MD Anderson have been able to bring it down to 
my level. 
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 The final component then of information as an uncertainty management strategy 
is providing additional information to previvors upon leaving the clinical consultation.  
Previvors underscored the importance of providing “extra” information—handouts, 
brochures, websites, etc.—in order to help them manage their uncertainty after leaving 
the clinical encounter.  Caitlyn (a 37-year-old, Caucasian BRCA2 previvor) stressed this 
point to “have resources ready.”   
One thing [my genetic counselor] was decent but not great on was having 
resources lined up—like who can I go to for this and who can I go to for 
that…She just didn’t have enough of that set up…I would have loved some 
information about a gynecological-oncologist; I had to research that by myself 
online and find one on my own. Breast surgeons. She didn’t give me anything. 
None. Counselors if necessary. She said, ‘You may need all of these [resources], 
but I don’t have anything to give you.’…So I am now stuck at this where do I go 
next step? 
Because Caitlyn did not receive additional information upon leaving her genetic 
counseling appointment, she left feeling very scared and confused about what to do next 
and ultimately had to search online for the resources she needed, which in many ways 
made her even more uncertain about her future.  
In sum, the first important strategy that assists previvors in managing their 
uncertainty about the future is interacting with and being cared for by clinicians who are 
knowledgeable about BRCA, provide information, answer questions, check 
understanding, and provide additional resources at the end of the consultation.  Because, 
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as Sophia (a 33-year-old, Chinese BRCA2 previvor) concluded, “Information is an 
effective coping mechanism.”  
Seeking Clinicians as a Partner in Decision-Making 
The second uncertainty management strategy previvors engage in is seeking 
clinicians as a partner for decision-making.  Since previvors experience uncertainties 
about when they might get cancer, how it might develop, and who they may leave 
behind, clinicians who encourage and engage in shared and informed decision-making 
assist previvors in managing their uncertainties.   
To do this—and extending the previous uncertainty management strategy—
clinicians should provide previvors with all the information surrounding their health 
risks, possible health decisions, and each decision’s benefits and consequences.  Jenelle, 
a 41-year-old, Caucasian and Ashkenazi Jewish BRCA1 previvor, described how her 
clinicians engaged in informed decision-making by discussing surgical preventative 
options but then letting her make the decision.  
I actually switched gynecologists because I needed someone who could discuss 
with me the pros and cons of making these different decisions…Because I 
needed someone who was going to be like, ‘Yes, we can get you looked at every 
six months. Yes, we can do the blood test for ovarian cancer, which is a CA125 
test. And a lot of physicians will say, ‘Well, it’s very nonspecific, not even worth 
doing it,’ but for me I needed to have it done…So I ended up switching to a 
gynecological-oncologist who would be willing to do those procedures…The 
oncologist was very open to that fact that it is my decision. Because the data said 
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this [referring to a preventative mastectomy] isn’t absolutely what has to be done, 
he was very careful with how he supported me if I wanted to do it, but was also 
saying at the same time, he was upfront with ‘I don’t know what this will mean 
or not mean, and it is a big procedure.’  
So Jenelle effectively managed her uncertainties in that encounter because her clinician 
provided her with all the information about increased surveillance and preventative 
surgeries and then stated he would support her final decision.   
Indeed, it is important for clinicians to maintain a balance between not pressuring 
previvors to choose a particular health option while also providing their own medical 
advice.  Previvors want their clinicians to be honest and straightforward with them.  For 
instance, Jennifer (a 30-year-old, Caucasian BRCA2) illustrated the frustration she 
experienced with her breast surgeon when he would not give her clear advice to help her 
make a decision.  
I tried to talk to him about the preventative mastectomy and [get] his thoughts... I 
mean, as a patient, I personally, I look to my doctors for support and opinions 
and advice, and I know that generally speaking, they’re not supposed to give you 
their personal opinion, but it’s so much more difficult when you’re relying on the 
expertise, and they say, ‘Well, I can’t really tell you what you should do.’ I mean 
you just want someone to give you an honest response. 
In contrast to Jennifer’s experience, Maria (a 32-year-old, Caucasian BRCA2 
previvor) praised her breast surgeon because she gave Maria “real answers” to her 
questions especially about decision-making.  Maria loved how her clinician would give 
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her personal answers about what type of preventative health decision she would make.  It 
made Maria feel like the clinician was a “real person” and understood her situation.  And 
in the end, Maria and her breast surgeon made the decision together, which helped Maria 
manage her uncertainty. 
Jennifer’s frustration and Maria’s satisfaction with clinicians’ decision-making 
approaches highlight how important patients’ preferences are in clinical consultations.  
When engaging in either shared or informed decision-making, it is essential for 
clinicians to ask previvors for their preferences as well as respect their preferences.  For 
example, Kelly, a 44-year-old, Caucasian BRCA1 previvor, illustrated how her 
clinicians at MD Anderson never pressured her into making a decision about undergoing 
a preventative mastectomy or not. The clinicians simply provided all the information and 
made sure she understood the options so she could make her own decision.  Similarly, 
Nancy (40-year-old, Caucasian BRCA2 previvor) explained,  
So you know, [my clinicians] have been able to tell me their recommendations, 
but it’s never been a high-pressure thing. It’s always, you know, here are the 
options, but you need to make the choice, and whatever decision you make, you 
know, we stand by you. 
Again, by not feeling pressured and feeling supportive by her clinicians, previvors like 
Nancy and Kelly are able to make a decision that works best for them.  
Finally, as touched on above, once the previvor makes a decision, the clinician 
should offer support, affirmation, and reassurances regarding that decision.  Also, the 
clinician should not judge the previvor’s final decision.  Veronica (a 38-year-old, 
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Caucasian BRCA2 previvor) described her interaction with her breast surgeon after 
receiving her positive test results from the genetic counselor.   
My husband and I had pretty much decided that was what we were going to do, 
and then I had those fears of ‘Oh no, what if they [referring to her clinicians] say 
I shouldn’t [do the mastectomy]’ or what if, you know, like I was having doubts 
[about the surgery], but then talking with [the doctor] just sort of reaffirmed that 
that was the path I wanted to take. 
In brief, the second helpful uncertainty management strategy is seeking clinicians 
as a partner for shared and informed decision-making.  Doing so includes seeking 
patients’ preferences about decision-making, respecting patients’ decisions, and 
providing reassurances once decisions are made, which ultimately assists previvors in 
managing their uncertainties in medical encounters.   
Seeking Clinicians as an Emotional Support 
The third uncertainty management strategy previvors engage in is seeking 
clinicians as an emotional support.  Generally, physicians who acknowledge, validate, 
and discuss previvors’ feelings, are empathetic and compassionate, actively listen, seek 
to understand previvors’ situations, build trust, and are concerned about previvors’ well-
being assist previvors in coping with an uncertain future and help previvors make the 
best decisions for themselves.  In the present study, many previvors sought clinicians 
who would assist in the emotional side of testing positive for BRCA and making health 
decisions; the previvors who did not have clinicians who supported them emotionally 
emphasized the desire for clinicians to help them cope by providing emotional support.   
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For example, when discussing the role her clinicians played in helping her cope 
with her high cancer risk and the associated stress she experienced, Jamie (a 27-year-old, 
Caucasian BRCA2 previvor) talked about how her primary care physician would 
occasionally ask how she was doing emotionally.  
 She asked how I was doing with this, and we talked about everything. And now I  
am okay with it [referencing high cancer risk]. I am at a really good place now, 
and I have accepted it. It is what it is. I can’t change it. I don’t have control over 
it; I just have control over what I do and how I respond to it. And so I am not 
going to let it control and ruin my life…She was just supportive.  
By asking about her feelings throughout the journey, Jamie was able to process her 
emotions, which helped her cope and manage her stress and uncertainty.   
In addition to asking about emotions, another helpful thing clinicians can do is 
treat previvors’ as patients who have emotions, which influence their experiences.  
Camille, a 47-year-old, Caucasian and Ashkenazi Jewish BRCA2 previvor, described 
how her plastic surgeon helped her cope with the emotional, uncertain side of having a 
high cancer risk by being concerned for her “full well-being.” 
I just felt like he wasn’t the nose job plastic surgeon—Yeah we will fix that and 
then I am done with you. I definitely felt like he was concerned for my full well-
being not just his little part of the job. That was helpful. I mean you have your 
support from your family and friends, but on the medical side, it felt really good 
to be supportive on that end as well…He showed an absolute sensitivity. First of 
all, as a man, there is just no reason for him to get it, and I felt like he did. When 
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he would talk about how I was doing in all of my follow-up appointment, well I 
had some issues when they cut my stomach hip to hip, and I had a lot of healing 
to go through and had a lot of issues that caused it to take longer, but I just felt 
like when I went in to meet with him, he wanted to know how I was doing 
emotionally with this, and the fact that I was having to deal with a wound weeks 
longer than I should have. And also, when my husband was with me, he wanted 
to know how he was doing with it, and then when he wasn’t with me, he wanted 
to know how our relationship was doing…so totally above and beyond…He was 
just completely aware of how emotional this whole process is for a woman.   
Camille effectively managed her uncertainty because her clinician focused on her as a 
whole person not just a body part to fix and constantly checked in to see how she and her 
husband were feeling emotionally.  
Third, clinicians can provide emotional support through physical touch. Skylar, a 
30-year-old, Caucasian and Hispanic BRCA1 previvor, asserted the most memorable 
moment during her health journey was when her clinician demonstrated care and 
concern for her through physical touch.  Specifically, Skylar’s plastic surgeon held her 
hand before she went under for her preventative mastectomy.  Through this simple act of 
holding her hand as the drugs caused her to fall asleep, Skylar did not feel alone 
anymore and felt supportive emotionally.  
Overall, clinicians should help previvors deal with the intense emotions 
associated with a high cancer risk and making preventative health decisions.  Clinicians 
who are concerned about the whole person, acknowledge and support the emotional part 
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of testing positive for BRCA, and ask about emotions assist previvors in managing their 
uncertainties.  
Seeking Referrals from Clinicians for Emotional Support  
The last uncertainty management strategy, least performed by previvors’ 
clinicians but highly desired, is seeking referrals from clinicians regarding emotional 
support.  This strategy includes two types of emotional support referrals—social 
support/social network groups and therapists/counselors/psychologists. I first discuss 
social support and social network groups as a way to cope with uncertainty. 
Sometimes clinicians’ emotional support is not enough to help previvors cope 
with their uncertainties.  Thus, previvors want their clinicians to provide referrals to 
local and online social support/social network groups and sites.  Doing so connects 
previvors to people who are in similar situations—people who have a large family 
cancer tree, people who have had similar traumatic cancer experiences, and people who 
have similar questions and concerns about dealing with a high cancer risk.  Ultimately, 
connecting previvors with individuals who have similar situations helps previvors 
because they hear about different experiences and decisions as well as feel like they are 
not alone in their health journey.  
Previvors suggest two ways clinicians can provide this emotional support. First, 
clinicians such as genetic counselors, breast and plastic surgeons, gynecologists, and 
oncologists should provide information about social support groups.  Clinicians can give 
brochures and handouts about groups focused on assisting previvors as well as a list of 
credible websites to visit.   
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For example, FORCE and Bright Pink, two popular organizations committed to 
previvors and their families, would be excellent resources to share with previvors.  
Nancy (a 40-year-old, Caucasian BRCA2 previvor) explained how after receiving her 
positive test results the genetic counselor pointed her to FORCE and Bright Pink’s 
websites.  Once she visited the websites, Nancy realized even though she felt like she 
was in her “own little circle of the world,” there were in fact other people out there “who 
are ten steps ahead of you,” which assisted in managing her own uncertainties.  
In fact, these groups, especially FORCE, were praised as wonderful social 
support networks.  Jenelle, a 41-year-old, Caucasian and Ashkenazi Jewish BRCA1 
previvor, proclaimed:  
…It has been wonderful! The people in FORCE, for my sister and me, have just 
helped us so much through this. I mean I am so thankful for these women; I mean 
they have gone above and beyond support. Just amazing. Like as far as emails 
and calls; they made a meal when each of us came home from the hospital [from 
surgery]…To see real people in your community tell you they are so happy they 
did this, and they feel and look great just makes a huge difference. 
Yet despite that benefits of organizations like FORCE, as Carly’s (a 31-year-old, 
Caucasian and Ashkenazi Jewish BRCA1 previvor) comment reveals most of the time 
clinicians do not provide previvors with information about these organizations unless 
requested.  Carly talked about how her breast surgeon gave her information about a local 
FORCE chapter when she was deciding whether or not to undergo a preventative 
mastectomy.  She said, “And it wasn’t until I asked her if she knew of anybody who 
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would had done [a mastectomy] preventatively that she told me about the local FORCE 
coordinator and gave me her card and information.”  Providing such resources is 
essential for previvors to receive the emotional support they need.  
Additionally, previvor Facebook groups are helpful resources for managing 
uncertainties.  Example groups include the following: Previvors, Young Previvors, 
BRCA Sisterhood, BRCA Advanced 101 and 102, BRCA Commons, and groups 
designed for the different health decisions (e.g., Young Previvors’ Surveillance Sisters 
and Prophylactic Mastectomies).  For instance, Sophia (a 33-year-old, Chinese BRCA2 
previvor) emphasized how the Facebook groups she is a part of have been instrumental 
in providing emotional support especially as it relates to making health decisions.  
The second suggestion previvors discussed is to have clinicians match their 
BRCA+ patients with other BRCA+ patients.  Patients could be matched according to 
who has the same BRCA status, similar demographics, or most importantly, who has 
chosen similar health decisions.  Matching previvors with similar others would help 
previvors provide support for each other and learn more about the possible health 
pathways.   
For instance, Anna, a 44-year-old, Caucasian and Ashkenazi Jewish BRCA1 
previvor, stated how nice it would be if clinicians would ask their current previvor 
patients if they would be willing to serve as a contact for other previvor patients.  Simple 
questions like, “Can I use you as a contact? Would you be open to talking to other 
patients of mine about [your] experience?” would be extremely helpful.  Also, Anna 
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suggested providing patient testimonials on clinicians’ websites.  That way, patients 
could learn more about BRCA+ patients’ experiences and decisions.  
Yet in addition to providing social support groups and building a previvor 
patients network, previvors also want their clinicians to provide referrals for therapists, 
counselors, and/or psychologists.  Such referrals assist previvors in coping with intense 
emotions.  Unfortunately, not many previvors received such referrals.  In the present 
study, sometimes the clinician simply provided the therapist’s name “just in case.”  
Sometimes the clinician told the previvor his office employed a full-time psychologist 
but did not discuss or encourage seeing the psychologist.  But on two occasions, 
previvors exemplified so much verbal, physical, and emotional concerns about testing 
positive, cancer fears, and making the right health decision, the clinician did expressly 
provide a referral.  
However, more often than not, previvors did not receive referrals to therapists.  
Thus, the previvor had to take matters into her hands.  This was the case for Addison (a 
33-year-old, Caucasian BRCA1 previvor).  Addison sought out a therapist to help her 
cope and “sort out [her] relationship with BRCA” because she did not feel enough 
emotional support from her clinicians.  She described her experience in therapy:  
We just talked about it a lot. I won’t go into everything that we talked about in 
therapy, but she really helped me come to terms with feeling like I had something 
in my future, and she helped me face my fear. And she also helped me to 
recognize my emotions and be able to be more perceptive about them. Where I 
realized that I started investing so much feeling in the future and things…A lot of 
  74 
what we did [revealed] that I was constantly talking about the future, maybe not 
really just cancer, but other things, and she really helped me to come back to the 
present and live in the present and be happy with the present. Knowing that 
there’s nothing I can do about the future, no matter what happens. And there was 
a lot of relief and power in that. It is something I still work on today. I mean, I 
think we all do. 
For Addison, seeing this therapist was the most helpful thing a clinician did for her to 
help her cope with her uncertainties.  Thus, because of her experiences, she stressed 
clinicians need to provide referrals to previvors when needed.  
In short, the final uncertainty management strategy previvors enact is seeking 
referrals from clinicians regarding emotional support.  Previvors who are having a 
difficult time coping with their high cancer risk desire their clinicians to provide referrals 
to social support/social network groups as well as therapists, counselors, and/or 
psychologists.  Doing so assists in managing emotional and medical uncertainties.   
Summary   
Overall, there are four strategies previvors engage in to manage their 
uncertainties.  First, previvors seek clinicians as an informational source—wanting 
clinicians who are knowledge, easy to understand, and provide as much information as 
possible.  Second, previvors seek clinicians as a partner for decision-making, desiring 
their clinicians to provide information about all possible health options while guiding 
and supporting their decisions.  Third, previvors seek clinicians as an emotional support 
because their own emotions can be overwhelming and difficult.  Finally, when 
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clinicians’ emotional support is not sufficient, previvors seek referrals from clinicians 
for social support groups and therapists.  
Research Question 2 
Research question two asked how do previvors’ uncertainties influence their 
health decisions in clinical encounters. Analysis revealed that the following contributed 
to previvors’ decisions: 1) risk perception of developing cancer, 2) scares of identifying 
potential cancer, 3) traumatic family experiences with cancer, and 4) current life status.  
In the current study, such factors were not present in all previvors’ stories, but a large 
majority of the previvors did discuss one or more of these factors and how the factors 
ultimately influenced their health decisions.  
There are three main health decision pathways for previvors.  First, after testing 
positive for the BRCA gene, previvors can engage in increased surveillance—attending 
medical consultations every six months to check for cancer through clinical breast 
exams, mammograms and MRIs, and transvaginal ultrasounds and CA125 blood tests.  
Second, previvors can undergo chemoprevention, which involves injecting 
chemotherapy medication into one’s body to reduce the likelihood of developing cancer.  
Or third, previvors can undergo preventative surgeries such as a preventative bilateral 
mastectomy, oopherectomy, and hysterectomy.3  
In the present study, previvors made a variety of decisions with preventative 
surgeries as the most common decision.  Four previvors shared that they are engaging in 
                                                
3 A preventative bilateral mastectomy is the surgical removal of one’s natural breasts in order to prevent a 
cancer. An oopherectomy is the surgical removal of one’s ovaries, and a hysterectomy is the surgical 
removal of one’s uterus in order to prevent cancer.  
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increased surveillance.  One previvor is currently trying chemoprevention, but the 
majority of previvors (e.g., 31) have undergone preventative surgeries (see Table 1).  
Specifically, 17 previvors have completed a preventative double mastectomy, also 
referred to as a prophylactic double mastectomy or preventative bilateral mastectomy.   
 
 
 
Table 1. List of Previvors’ Health Decisions 
Increased surveillance (4) Chemoprevention (1) Preventative surgeries (31) 
Lacy (breasts) 
Jasmine  
Theresa (planned PBM) 
Alexa (all) 
Lacy Savannah 
Mary 
Elizabeth 
Carly 
Jenelle 
Madison 
Janet 
Jacklynn 
Madeline 
Kelly 
Sarah 
Jamie 
Camille 
Nancy 
Lacy (ovaries) 
Tara 
Anna 
Sue  
Jennifer 
Samantha 
Rebecca 
Maria 
Bailey 
Veronica 
Shauna 
Skylar 
Sophia 
Caitlyn 
Addison 
Tiffany 
Gabriella 
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Six previvors have undergone either an oopherectomy or hysterectomy.  Lastly, eight 
previvors have done a preventative double mastectomy and either (or sometimes both) 
an oopherectomy or hysterectomy (see Table 2).  Because the most common health 
decision for previvors was a preventative surgery, I first describe the reasons for this 
particular decision.  
 
 
 
Table 2. List of Types of Preventative Surgeries 
Preventative Surgeries 
Mastectomy Oopherectomy and/or 
Hysterectomy 
Both 
Mary 
Elizabeth  
Carly 
Madison 
Janet 
Madeline 
Jamie 
Camille 
Tara 
Jennifer 
Maria 
Bailey 
Veronica 
Skylar 
Sophia 
Addison 
Gabriella (maybe O/H) 
Jenelle (put has planned 
PBM)  
Kelly (put has planned 
PBM)  
Lacy (minus PBM with no 
intention)  
Anna  
Sue  
Caitlyn  
 
 
 
Savannah 
Jacklynn  
Sarah 
Nancy 
Samantha 
Rebecca 
Shauna 
Tiffany 
 
 
 
 
 
 
Surgical Health Decisions 
The majority of the present study’s previvors chose preventative surgeries to 
manage their high cancer risk.  Generally, previvors who underwent preventative 
surgeries had the following beliefs, experiences, or circumstances: 1) believed they 
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would get cancer at some point in their lives, 2) experienced death (or severe cancer 
diagnoses) in their family, 3) had physicians identify suspicious lumps or spots during 
increased surveillance appointments, 4) were married, and 5) had finished bearing 
children. In other words, for many previvors, the medical and familial uncertainties are 
simply too much to handle, and so they choose the most drastic health option—surgery.  
In this section, I first describe the main reasons why previvors decided to undergo 
preventative surgeries, and then I discuss why certain previvors chose to undergo a 
preventative mastectomy versus an oopherectomy and/or hysterectomy.  
Previvors choose to undergo preventative surgeries for several reasons.  The 
most prominent reason for undergoing a preventative surgery was previvors did not want 
to live in an ongoing uncertain world.  Previvors did not want to worry constantly about 
when they might get cancer during their lifetime.  Previvors discussed by undergoing a 
preventative mastectomy, for instance, they could choose the day, the time, and the 
place, thus giving them some control over their own body.   
Also, previvors do not ever want to get cancer. They do not want to go through 
the many surgeries, medical appointments, various treatments, and experience the 
numerous, unpleasant side effects.  For example, Carly, a 31-year-old Caucasian and 
Ashkenazi Jewish BRCA1 previvor, stated,  
I pretty much decided that I [had] a hundred percent guarantee that I was going to 
get breast cancer based on my family history, so I think once I decided that, it 
was a matter of time when I was going to have a double mastectomy, and I put 
the timeline that I needed to do it by age 40, but I ended up having it when I was 
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35. So I was turning 35, and it [was] hanging over my head, the surgery. I guess I 
was dreading it. I knew I was going to have to have it. I thought, you know what, 
I should be able to move forward in my life. I needed to get it [referencing the 
surgery] behind me.  
So even though Carly was hesitant to do a preventative surgery, she did not want to 
worry about when she might develop cancer.  Carly said she always knew getting the 
surgery was her best chance to reduce her high cancer risk, and she is very happy she 
made the decision.  In short, previvors—who are certain they will get cancer at some 
point in their lives—often choose to undergo preventative surgeries because it manages 
the uncertainty.   
The second reason previvors decided to undergo preventative surgeries was 
twofold. First, previvors did not want to experience uncertainty each time they attended 
a medical consultation.  Camille (a 47-year-old, Caucasian and Ashkenazi Jewish 
BRCA1 previvor) explained it this way:  
I mean, like I said, from a very young age, I always felt like I was predetermined 
to have breast cancer, and just from an emotional standpoint watching my mom 
go through that, and it's freaking me out and everything, but then to have those 
kind of numbers, to be faced with that I just… there’s no way…The heightened 
surveillance just wasn’t feeling like enough for me. And then, like I said, to have 
that biopsy, which was extremely uncomfortable, and I knew that this was going 
to become a sort of a repetitive thing. 
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Second, previvors did not want to worry if the clinician would find any 
suspicious lumps or spots during the consultation.  For example, when Maria (a 30-year-
old Caucasian BRCA2 previvor) attended a medical consultation, the clinicians found 
several possible lumps.  She explained,  
So after an ultrasound with biopsy was done, they’re like let’s do an MRI with a 
biopsy. So I scheduled that appointment, and while I was waiting for that one to 
happen, I just decided to schedule the surgeries for the preventative bilateral 
mastectomies because I was looking at six biopsies...I was like going crazy by all 
of this, so I decided, you know, just go ahead with the surgery and be done with 
all of that. 
Like Carly and Maria, previvors do not want to wait every six months to hear if their 
clinicians found something suspicious in their breasts or ovaries.  They do not want to 
worry if cancer is developing in their bodies.  They do not want cancer to define their 
lives.  Therefore, removing one’s natural breast tissue, ovaries, and/or uterus is worth it 
because it reduces those uncertainties.   
The last reason previvors decided to undergo preventative surgeries related to 
their role as a mother.  Many previvors discussed a main reason for undergoing a 
preventative mastectomy, oopherectomy, and/or hysterectomy was their children.  They 
did not want their children to grow up without their mothers.  They do not want their 
children to ever see them sick.  They did not want their children to ever worry about 
losing their mother to cancer.   
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Such feelings and worries relate back to previvors’ family experiences with 
cancer, which left deep, unhealed scars, and previvors did not want their children to be 
scared about losing them when they knew they could do something about it.  For 
instance, when discussing why she underwent a preventative mastectomy, Jennifer (a 30-
year-old Caucasian BRCA2 previvor) talked about her children.  
I have three boys actually. One of them is only 1½, and so, it was also really 
scary for me to think ‘Oh my gosh,’ you know, what if I don’t have as great of an 
outcome, you know. [I was] worrying about whether or not my children [were] 
going to know how much I love them. If they were going to remember me, if 
something terrible happened because they’re young. 
So having preventative surgeries was worth it to Jennifer because the surgeries alleviated 
her uncertainty, fear, and worry about developing and dying from cancer, and thus she 
could focus on participating in her children’s lives.   
In addition to these main reasons, age was also an indicator for the specific type 
of preventative surgery previvors chose.  Most previvors close to or over age 40 had or 
planned to undergo a preventative oopherectomy and/or hysterectomy.  Such decisions 
are common because experts recommend previvors remove their ovaries between 35 and 
40-years-old and after having children (Friedman, Sutphen, & Steligo, 2012).  Moreover, 
ovarian cancer is harder to detect, and consequently, when this cancer is discovered, 
oftentimes it is extremely advanced and commonly results in death.  Consequently, if the 
previvor is done having children, it is recommended to remove these body parts.  
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Ages for previvors who chose a preventative double mastectomy ranged from 27 
to 51, but the majority of the previvors in the current study completed the surgery 
between ages 30 and 35 years old.  This decision is often made by women who have the 
BRCA gene, have a large family history of cancer, and more importantly, have relatives 
who were diagnosed and/or died before their 40s (Friedman, Sutphen, & Steligo, 2012).   
There are, however, several consequences to having preventative surgeries.  For 
one, an oopherectomy and hysterectomy causes the previvor to go into early menopause, 
which is often unpleasant and distressing.  Additionally, this surgery can have an impact 
on women’s sexual enjoyment.  Side effects include vaginal dryness and occasional pain 
during intercourse (Roth Port, 2010).   
Like an oopherectomy and hysterectomy, there are consequences for undergoing 
a preventative mastectomy.  On a personal level, many women have emotional 
attachments to their breasts, and many think their breasts make them a woman. Of 
course, breasts are sexualized body parts, but breasts are also functional, for example 
with breastfeeding.  Also, undergoing a preventative mastectomy can impact women’s 
body image. In fact, the main reason why women do not choose a preventative 
mastectomy is due to body image. Lastly, when removing breast tissue, there is often a 
lack of stimulation in the nipples thus affecting sexual enjoyment (Roth Port, 2010). Yet 
despite the side effects, the previvors in the present study expressed they were not as 
concerned about these issues because the surgeries helped them manage uncertainty 
surrounding their high cancer risk.   
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It is important to note after testing positive for the BRCA gene, many previvors 
engaged in increased surveillance first; however, they eventually decided to undergo 
preventative surgeries because increased surveillance is not preventative.  In other 
words, uncertainty still exists.  The fear of the unknown can keep growing and growing, 
and for many previvors, the fear and uncertainty is simply too much to handle.  
Previvors feel something has to be done, and the ‘something’ is usually a preventative 
double mastectomy and sometimes a preventative oopherectomy and/or a hysterectomy 
and sometimes both.  
Sarah’s (a 56-year-old, Ashkenazi Jewish BRCA1 previvor) health decisions 
illustrate this perspective that increased surveillance is not preventative.  Initially, Sarah 
did not want to undergo a preventative mastectomy, yet she ended up doing it because 
people close to her were dying from cancer.  One such woman was a therapist in her 
school who was diagnosed with non-smoking related lung cancer.  Sarah described her 
as a really young health nut who “within a year [went] from being like this beautiful 
vibrant person to wearing a wig and having no eyebrows.”  Knowing someone with 
cancer personally who was completely healthy was very difficult for Sarah.  In one 
interaction Sarah will never forget, this therapist and colleague said to her, “You have to 
do whatever you can do to avoid having chemotherapy…Because it’s not the cancer. It’s 
the chemotherapy that’s killing us.”  Because of this interaction, not long after, Sarah 
went to see an oncologist, a breast surgeon, and gynecologist.  In short, Sarah’s 
perspective changed because she realized she had the opportunity to do something 
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preventative so she would never get cancer and never have to undergo chemotherapy 
like her friend.  
So engaging in a preventative surgery helps manage uncertainty because it is the 
most effective medical way to reduce one’s high cancer risk.  In fact, removing one’s 
natural breast tissue or ovaries or uterus reduces one’s risk of developing cancer from 
the 60-80 percent to 5 percent (Roth Port, 2010)!  In other words, these surgeries 
“defuses the time bomb,” makes the previvor “feel healthy,” and ultimately “feel like she 
is reducing her risk as much as she can.”  Thus, even though preventative surgeries mean 
giving up one’s breasts, and sometimes ovaries and uterus, previvors think it is worth it.  
Indeed, many participants talked about a “sense of relief” or a “peace of mind” or 
“mind resting” produced after undergoing a preventative surgery.  For instance, when 
asked how she felt after completing her surgeries, Anna (a 44-year-old, Caucasian and 
Ashkenazi Jewish BRCA1 previvor) expressed, “The number one feeling I felt when I 
woke up [from surgery] was relief…Oh, huge weight. Huge weight lifted!”  
Furthermore, she said she always asks previvors how they feel after their surgeries, and 
they always say the same thing—Getting the surgeries provided an immense amount of 
relief because they no longer have to worry about their high cancer risk. 
Summary   
In brief, preventative surgeries help previvors manage their medical and familial 
uncertainties.  By undergoing a preventative mastectomy, oopherectomy, and 
hysterectomy, previvors no longer have to worry about when they might get cancer, do 
not have to deal with the peaks and valleys or personal scares each time they attend a 
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medical consultation, are not reminded as much about past family experiences with 
cancer, and know they will have the best chance to watch their children grow up.  
Therefore, previvors view this health decision as getting rid of the death sentence 
mentally associated with a cancer diagnosis.  As many previvors described, “it’s 
choosing life over your body parts.”  
Nonsurgical Health Decisions 
Yet as discussed earlier, surgical options are not the only way to deal with one’s 
high cancer risk.  Despite the preference for preventative surgeries, previvors can also 
engage in nonsurgical options such as increased surveillance and chemoprevention.  
Increased surveillance typically encompasses rotating between MRIs and mammograms 
to check breasts and ultrasounds and CA125 tests to check ovaries every six months. The 
goal of increased surveillance is to catch the cancer early enough so there can be a 
favorable diagnosis, a minor surgery like a lumpectomy, and no radiation or 
chemotherapy.  Chemoprevention includes using medication (e.g., Tamoxifen) to reduce 
one’s breast cancer risk.  This health decision is debated in the medical field; there is 
some research which supports chemoprevention, while other research questions 
chemoprevention’s effectiveness for individuals with BRCA (“Chemoprevention and 
breast cancer,” 2014).  
In the present study, nonsurgical health decisions were not common.  Only four 
women opted for a nonsurgical pathway.  One previvor is currently undergoing 
chemoprevention through a high-risk program at Stanford University as well as doing 
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increased surveillance for her breasts, and the three other women are engaging in 
surveillance for their breasts and ovaries.  
There are several reasons why these women decided not to engage in 
preventative surgeries.  First, Jasmine (a 32-years-old, Caucasian and a BRCA2 
previvor) who chose increased surveillance talked about the desire to have children and 
thus is “not ready to give up any body part yet.”  She said,  
I’m just thinking, I mean even though I’m not yet 33, I keep thinking about some 
of these girls who talk about having their ovaries removed, and I’m freaking out 
like ‘Don’t jump the gun just yet!’ You know?! ‘You’re young.’ I know anything 
can happen doing... Anything can happen, but I just, I feel like maybe there’s not 
enough information out there to make us kind of choose. I mean it is one thing 
not to breastfeed, but it’s another thing to not to have kids. So even if you’re 25, 
you know. I mean when I was 25, I wanted kids one day and hated them the next. 
And now that I’m 32, I want kids so bad, and I don’t have anyone to do that with, 
and I don’t make enough money to be able to do it on my own. 
So younger previvors may choose to undergo increased surveillance because they have 
not had children.  In addition to wanting kids, Jasmine also emphasized it is important to 
“Keep your stuff!” She explained when a person is young, she should enjoy her breasts 
while she can and not be in a hurry to get rid of them.  
Along the same lines, a second reason why previvors choose increased 
surveillance is their breasts’ importance.  As mentioned earlier, many women are 
emotional attached to their breasts because breasts make them feel like beautiful, sexy 
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women.  For example, when discussing why she is engaging in surveillance, Alexa (a 
38-year-old, Caucasian BRCA1 previvor) stressed she is “not through with her 
sexuality.”  Alexa explained she simply does not want to remove her natural breasts 
because her breasts represent her sexuality, and she is not ready to give that up yet. 
The third previvor—Lacy (a 51-year-old, Caucasian BRCA2)—picked a variety 
of health decisions, which provide further insight into previvors’ health decisions.  First, 
she decided to undergo a preventative oopherectomy and hysterectomy, but then opted 
for increased breast surveillance and chemoprevention.  Lacy had three main reasons for 
why she decided not to undergo a preventative mastectomy but did the preventative 
surgeries for ovarian cancer.  The first reason was her age.  She stated,  
I mean I think it more than has to do with the age you’re at. I was 48 when I was 
identified BRCA+, so I know I didn’t get cancer at 35, you know. I know I didn’t 
get breast cancer at 40 or whatever. So it’s not like I’m look at 60 years of 
screening, you know. 
If Lacy had tested positive for BRCA earlier in her life, she acknowledged she might 
have considered a preventative mastectomy more, but given her current age, the most 
pressing issue was the possibility of developing ovarian cancer.  
The second reason for her health decision was her clinicians’ recommendations.  
Lacy’s clinicians recommended she immediately remove her ovaries and tubes to 
prevent ovarian cancer.  She explained her decision-making process:  
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Well, when I spoke with the genetic counselors, they said their recommendation 
for me was that I do have my ovaries and tubes4 removed…So [the clinicians] 
were pretty straightforward. That was their recommendation because of the risk 
for the ovarian cancer is a lack of good screening for ovarian cancer, and you 
know, my age and stage of my life… 
Lacy also talked about how her clinicians discussed with her there is not a lot of 
information to date regarding breast cancer risk reduction and mastectomies.  
For the breast cancer risk, [the clinicians] said, pretty much said, ‘There are two 
ways you could go,’ you know, and they did not say one or the other would be 
their recommendation...And there wasn’t much data on it, or the mastectomy, 
and they did also say that actually the majority of folks [do] surveillance, not 
mastectomy, which, you know, I think if you read, if you just look in the media, 
you probably think the other way because it’s a lot more dramatic the things they 
say… 
Her clinicians explained further to Lacy each option’s risks and benefits.  She reported,  
... If you do surveillance, the risk is you could get cancer, you know. So you 
might have to have cancer and cancer treatment, but you also might never and 
might never have plastic surgery, and if you do preventive mastectomy, you 
won’t ever have to have cancer treatment, but you will by definition do the 
mastectomies... 
                                                
4 Removing the ovaries and falopian tubes is commonly referred to as a bilateral salpingo-
oophorectomy (BSO).  
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Clearly, Lacy’s clinicians’ recommendations significantly influenced her health 
decision.  The risk of undergoing a preventative mastectomy surgery and possible 
surgical complications did not outweigh the benefits.  Lacy also decided if it ever felt 
like surveillance was not enough, she could simply change her mind and do the surgery 
then. 
The last issue, which influenced Lacy’s health decision, was watching her mother 
suffer from ovarian cancer.  Lacy’s mom was diagnosed with ovarian cancer at a later 
stage in life and thus the cancer was advanced Stage IIIC.  Furthermore, it was her 
mother’s diagnosis that alerted Lacy to undergo BRCA testing in the first place, and as 
such, the ovarian cancer was something she was more concerned about at the time she 
received her positive test results.  She explained,  
Having watched my mom have ovarian cancer, I was, you know, it wasn’t that I 
was looking forward to doing that surgery, but I was highly motivated to not get 
ovarian cancer…The ovarian surgery was certainly a first priority, you know. 
That’s what [the clinicians] presented to me, and as far as how I looked at it, and 
I knew that if I chose down the road, I probably would do the mastectomy later 
after, you know, screening for some period of time, so that was a good way to, 
you know, initially do the more sort of high priority surgery… 
Finally, the last previvor is currently doing increased surveillance but is planning 
on undergoing a preventative mastectomy soon.  Theresa, a 34-year-old, Caucasian 
previvor, learned her BRCA2 status in February 2014, and as such, she has not had 
enough time to process everything and decide what she wants to do.  In addition, similar 
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to Alexa, Theresa disclosed she thinks her hesitation to do the mastectomy is due to the 
fact she does not want to part with her breasts.  She explicated,  
I want to say that it is not for superficial reasons, but I think it is for very 
superficial reasons. I’m still moving forward with the preventative mastectomy, 
because I think it will save my life; I don’t want to waste anymore of my life…I 
don’t want to know I could have prevented my own death. So now I am trying to 
reconcile with myself that I am doing something traumatic to myself for a 
preventative reason, as good of a reason as it is, and it is still kind of surreal…I 
know I will have all of the preventative surgeries, but it is really a question of 
when. 
Thus, Theresa’s struggle with increased surveillance and a preventative surgery reveals 
the tension between a preventative mastectomy’s benefits—reducing one’s cancer risk—
and a preventative mastectomy’s risks—what it does to the previvor’s body and morale.  
In fact, Lacy acknowledges this struggle too, despite her own health decisions.  
She discussed,  
Occasionally, I will think that I sort of re-talk all [referencing her decisions] of 
this through, but I haven’t come to any different conclusion about it yet, and I 
guess, you know, just having that uncertainty and that risk, I know some people 
really hate it. They just want to know and be done, but I have seen a lot of people 
go through mastectomy, and it’s a really big surgery, and it’s very hard. People 
often have complications, and you know, if I can avoid that that would be great. 
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So even though Lacy admitted increased surveillance is not the best health decision to 
reduce her uncertainties, she still has chosen this health route because of the 
uncertainties associated with undergoing a preventative mastectomy.  As a result, despite 
the fact that increased surveillance may invoke fear, anxiety, and worry, a surgical health 
option is not always previvors’ choice for managing her uncertainties.  
Summary 
Overall, a few previvors chose increased surveillance and/or chemoprevention as 
a way to manage their high cancer risk.  Reasons for choosing this particular health 
decision include the following: children, emotional attachments to breasts, body image, 
clinicians’ recommendations, and past familial experiences with cancer.  It is important 
to note, however, because the majority of previvors in the present study chose to 
undergo preventative surgeries, it is difficult to completely flesh out why previvors 
choose particular health decisions over others.  Yet this study’s findings do provide 
insights into why previvors, both young and old, might engage in preventative surgeries.  
In short, because preventative surgeries tend to be viewed as “extreme,” choosing to 
have a preventative surgery demonstrates uncertainty’s immense power on previvors’ 
lives.  
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CHAPTER IV  
DISCUSSION AND CONCLUSIONS 
 
Because of previvors’ high cancer risk, they live in a constant state of 
uncertainty—wondering not if they might get cancer but when.  Such uncertainty cannot 
always be eliminated and therefore must be managed.  Thus, the purpose of this 
dissertation study was to identify previvors’ sources of uncertainty and the ways in 
which they manage such uncertainties in clinical encounters as well as understand how 
the uncertainties influence previvors’ decision-making.  
Analysis revealed previvors experience medical and familial uncertainty, which 
manifests in the following ways: an unknown future, peaks and valleys associated with 
medical consultations, personal cancer scares, traumatic family cancer experiences, and 
being a mother and being present in children’s lives.  To deal with such uncertainty, 
previvors engage in particular uncertainty management strategies including seeking 
clinicians as an informational source, seeking clinicians as a partner for decision-
making, seeking clinicians as an emotional support, and seeking referrals from clinicians 
for emotional support.  Overall, previvors’ cancer risk perception, individual cancerous 
scares, traumatic family experiences, and current life status impact their health decisions.  
The findings are now discussed and then limitations and future directions are noted.  
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Theoretical Implications  
Uncertainty Revisited 
The present study reveals and supports previous research that uncertainty is 
inherent in health and illness experiences (Babrow & Kline, 2000) especially in 
clinician-patient communication about risk (Kasper, Geiger, Freiberger, & Schmidt, 
2008).  Broadly, previvors experience uncertainty because they are not able “to foresee 
the future and explain the past and through the experience of ambiguous or unpredictable 
events” (Berger & Bradac, 1982, as cited Miller, 2014, p. 234).  More specifically, the 
findings illustrate uncertainty is a living, breathing thing previvors must deal with each 
day (Roth Port, 2010), yet particularly in clinical encounters.  Previvors do not just 
worry about when they might get cancer, but also must cope with cancer worries every 
six-month during a medical consultation or when reflecting back to their loved ones’ 
battles with cancer.   
Therefore, the findings also reveal uncertainty is a complex phenomenon and 
should be approached as something to be managed not reduced (Brashers, 2007; Bylund 
et al., 2012; Epstein & Street, 2007).   As mentioned earlier, previvors undergo BRCA 
genetic testing to reduce their uncertainty about whether or not they have a high cancer 
risk, which initially may reduce that uncertainty, but if they test positive for the BRCA 
gene, different uncertainties may arise such as peaks and valleys, personal cancer scares, 
traumatic family experiences, and being a mother and being present for children’s lives.  
As such, previvors experience chronic uncertainty, and both clinicians and patients must 
learn how to manage such uncertainties.   
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Sources of Uncertainty   
Because uncertainty often cannot be eliminated and thus must be managed 
(Epstein & Street, 2007), an essential first step for uncertainty management is to identify 
the sources of uncertainty for the population at hand; doing so assists in understanding 
how uncertainty influences communication (Babrow & Kline, 2000; Bylund et al., 
2012).  As such, I first discuss previvors’ uncertainty sources and how such sources 
support and extend existent research.  
First, the present study’s uncertainty sources support past research’s sources of 
illness uncertainty.  When examining individuals living with HIV, Brashers et al. (2003) 
identified three sources of uncertainty in illness: medical, personal, and social.  Medical 
uncertainty sources, the most prominent in health care, include “issues of diagnosis, 
symptom patterns, systems of treatment and care, and disease progression or prognosis” 
(p. 502).  The current study’s sources of uncertainty (e.g., the unknown, peaks and 
valleys, and personal cancer scares) loosely reflect medical uncertainty.  For example, 
previvors’ belief that the future is always uncertain coupled with the belief cancer will 
be discovered at some point during their lifetime reflects the medical uncertainty 
property diagnosis (Brashers et al., 2003) and, more specifically, the inevitability of 
diagnosis as explained by Middleton, LaVoie, and Brown (2012).  Additionally, 
previvors’ uncertainty about cancer scares is related to ambiguous symptom patterns and 
unpredictable disease prognosis (Brashers et al., 2003).  When performing a self-breast 
exam or undergoing a mammogram or MRI, previvors worry about discovering a 
suspicious lump or change in their breasts.  Even after making particular health decisions 
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(e.g., increased surveillance or preventative surgeries), previvors are uncertain about 
treatment failure (Brashers et al., 2003), which ultimately heightens uncertainty about 
the unknown future.   
Second, previvors’ medical uncertainty of the unknown future is also related to 
risk or uncertainty about future outcomes (Politi, Han, & Col, 2007).  Politi and Street 
(2011) characterize being uncertain about future outcomes or events related to an illness 
or treatment as stochastic uncertainty (Politi, Lewis, & Frosch, 2013).  On the other 
hand, Han (2013) terms such uncertainty as probability, referring to the fundamental 
principle that future outcomes are not determined or fixed but rather are random (Han, 
Klein, & Arora, 2011).  An unknown future is a source of uncertainty for previvors 
because they do not know if/when their high cancer risk might manifest as actual cancer.  
In brief, the present study supports previous research that different health experiences 
and illnesses generate certain types of uncertainty (Brashers et al., 2003; Bylund et al., 
2012; Middleton, LaVoie, & Brown, 2012).   
Nevertheless, the current study’s sources extend beyond previous research 
identifying a third, important source of uncertainty—familial uncertainty.  Familial 
uncertainty includes traumatic, family experiences with cancer and being a mother and 
being present for children’s lives.  For some previvors, past experiences of watching 
loved ones battle cancer greatly enhances their fear and uncertainty of cancer and what 
cancer can do to the body.  For others, losing their mothers during their childhood and 
not wanting their own children to experience such loss is a significant source of 
uncertainty.   
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Though past research has not explored familial sources of uncertainty for 
previvors, some research has examined family relationships and breast cancer (e.g., 
Bylund et al., 2012; Fisher, 2010).  For instance, in genetic counseling, Bylund and her 
colleagues (2012) found mothers who were breast cancer survivors experienced 
uncertainty about their daughters’ cancer risk, identifying three main sources including 
disease risk, future cancer screening, and communicating relevant information to 
daughters.  Additionally, Fisher (2010) examined emotional support communication 
between mothers and daughters who were coping with breast cancer.  She learned 
sometimes daughters avoid discussing issues surrounding breast cancer with their 
mothers as a way to cope with such distressing topics.  In short, these sources of 
uncertainty speak to “the critical role family-related uncertainty plays in genetic testing 
decision making” (Bylund et al., 2012, p. 299) and reveal the emotional connection 
between mothers and daughters regarding breast cancer (Fisher, 2010).  
Uncertainty Management Strategies 
Since previvors experience various uncertainty sources, which can produce 
severe psychosocial side effects (Neville, 1998), it is essential to manage them (Epstein 
& Street, 2007).  Yet as the present study indicates, “uncertainty is multilayered, 
interconnected, and temporal,” and thus “the appropriateness and effectiveness of 
responses used to manage [uncertainty] are likely to vary across contexts and situations” 
(Brashers, 2001, p. 481).  
The current study identified the following four uncertainty management 
strategies: (a) seeking clinicians as an informational source, (b) seeking clinicians as a 
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partner for decision-making, (c) seeking clinicians as an emotional support, and (d) 
seeking referrals from clinicians for emotional support.  Overall, these strategies indicate 
communication plays an important role in managing uncertainty (Babrow & Kline, 
2000), and particularly, communication between health care clinicians, patients, and 
families is essential to the uncertainty management (Bylund et al., 2012).  I now discuss 
the identified uncertainty management strategies and how they support and extend past 
research.  
Seeking Clinicians as an Informational Source 
The first management strategy, and most commonly discussed by previvors, is 
seeking clinicians as an informational source.  In order to manage medical and familial 
uncertainties, previvors want clinicians who are knowledgeable about BRCA, provide 
information about cancer risk and possible health decisions, answer questions, confirm 
understanding of provided information, and offer additional resources as needed or 
desired.  Hence, it is first necessary for clinicians to assess previvors’ preferences for 
“what information they desire and what role they wish their clinicians to play” because 
doing so assists in managing uncertainty (McCormack et al., 2011, p. 1091).  
Prior research indicates information and thus knowledge are the main 
mechanisms for managing uncertainty (Brashers et al., 2003; Miller, 2014; Mishel et al., 
2005; Mishel, 1988).  Information enables individuals to interpret their situation, which 
can then provide closure for the uncertainty (Mishel, 1990).  For example, Miller (2014) 
found cancer survivors use information as a means to cope with illness-related 
uncertainty.  She reported cancer survivors seek information from their clinicians in 
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order to manage their uncertainty about their illness as well as their care.  Also, in a 
different study about cancer survivors, Mishel and her colleagues (2005) conducted an 
uncertainty management intervention for breast cancer survivors and found it improved 
knowledge about cancer and clinician-patient communication.  Clearly, receiving 
information is a helpful way to manage uncertainty.  
Seeking Clinicians as a Partner for Decision-making 
In addition to information, the second uncertainty management strategy is 
seeking clinicians as a partner for decision-making.  Previvors emphasize when their 
clinicians engage in shared or informed decision-making (e.g., shared: the clinician and 
patient decide together and informed: the patient decides given provided information 
from the clinician and other sources; Charles, Gafni, & Whelan, 1999), it helps them 
manage their uncertainties.  Additionally, respecting decisions and providing 
reassurances once decisions are made also assists previvors in managing their 
uncertainties in medical encounters.   
Past research supports this connection between uncertainty and decision-making 
(Epstein & Street, 2007; Kasper, Geiger, Freiberger, & Schmidt, 2008), yet also notes a 
significant knowledge gap about decision-making and risk communication (Bottorff et 
al., 1998).  In one study, Kasper and his colleagues (2008) examined decision-related 
uncertainty qualities for cancer patients in order to develop “a theory about people’s 
perception of decisional uncertainty and about the way it changes when they elaborate 
information relevant [to] decision[s]” (p. 43).  Interviews with cancer patients revealed 
uncertainty management as a pivotal challenge to coping with decisions about cancer, 
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thus demonstrating “uncertainty as the core content of the decisional communication” (p. 
43), thus similar to previvors’ experiences.   
Also, Bottorff and her colleagues (1998) conducted an extensive literature review 
on communicating cancer risk information.  The authors found cancer patients want 
clinicians to respect their preferences for decision-making (Vogel, Yeomans, & 
Higginbotham, 1993) and crave ample amounts of information in order to make 
informed decisions (Kelly, 1992).  Therefore, an effective approach to decision-making 
is a mutual-participation model where the patient and provider participate equally when 
making decisions regarding cancer risk (Kenen & Smith, 1994).  
Seeking Clinicians as an Emotional Support 
A third uncertainty management strategy is seeking clinicians as an emotional 
support.  Because previvors often express negative emotions such as worry, anxiety, and 
fear, they state when their clinicians acknowledge and validate their emotions, are 
empathetic, and are concerned about their well-being, previvors are able to manage their 
uncertainties.  Moreover, previvors are better able to cope with their uncertainties when 
physicians actively listen to previvors’ emotions and seek to understand their specific 
situations.  
The connection between emotions, uncertainty, and cancer has long been 
supported.  Previous research acknowledges the importance of addressing uncertainty’s 
emotional side (Bradac, 2001; McCormack et al., 2011).  Dean and Street’s (2014) three 
stage model of patient-centered communication for addressing cancer patients’ 
emotional distress notes two affective strategies—acknowledgement and validation of 
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emotions and empathy—which are helpful in managing uncertainty.  By acknowledging 
and validating emotions, clinicians can address patients’ emotional concerns, which may 
contribute to patients’ sense of feeling known by their clinicians (Anderson et al., 2008; 
Politi, Han, & Col, 2007; Street et al., 2009).  Furthermore, being empathetic, respecting 
patients, and communicating support makes patients feel their clinicians understand their 
emotions and experiences (Arborelius & Österberg, 1995; Eide et al., 2011).   
For example, one study examined uncertainty management and communication 
preferences for families coping with severe genetic diseases.  Through survey methods, 
Parrott, Peters, and Traender (2012) learned patients and their families’ negative feelings 
about a genetic condition directly related to the uncertainty management as well as the 
desire to communicate about the condition.  In other words, negative feelings were a 
mediating factor between illness uncertainty and uncertainty management.  Hence, an 
effective way to manage uncertainty is to communicate about negative emotions. 
Seeking Referrals from Clinicians for Emotional Support  
The final strategy previvors engage in to manage uncertainty is seeking referrals 
from clinicians for emotional support.  Sometimes receiving emotional support from 
clinicians is not enough to manage uncertainty and the associated negative emotions, and 
thus previvors seek out clinicians to provide referrals to social support and social 
networking groups as well as therapists, counselors, and/or psychologists.   
This last uncertainty management strategy is also supported by prior research.  
Coping resources like counseling services and social support groups have been found to 
be effective in managing patients’ emotional states (McCormack et al., 2011; Mishel et 
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al., 2005).  First, social support has been found to be a resource for alleviating 
uncertainty because it provides a solution to the problem at hand and can change the 
interpretation of the problem (Cohen, 2004; Michael et al., 2002).  What is more, social 
support assists in reducing the unpredictability of the illness experience (Mishel, 1997).  
In short, being a part of a satisfying social support network is associated with better 
coping skills and less uncertainty (Mishel & Braden, 1987).    
Second, sometimes a patient experiences psychological morbidity, which is 
beyond the clinician’s ability to help, thus requiring the clinician to provide a referral to 
a therapist to help the previvor cope with her negative emotions (Dean & Street, 2014).  
To provide a referral, the clinician should express his or her willingness to help and 
support the patient, review next steps with the patient, invite questions, build a 
partnership, offer to delay any decision-making, and summarize important content 
(Brown et al., 2002). Following such communicative steps is essential because many 
individuals coping with cancer are not referred to counseling services when needed the 
most (Hardman, Maguire, & Crowther, 1989; Keller et al., 2004; Maguire, Tait, & 
Brooke, 1980).  Overall, the present study demonstrates when addressing previvors’ 
uncertainties, “health care professionals and supportive others cannot apply a one-size-
fits-all solution when aiding in uncertainty management (Brashers et al., 2003, p. 194).  
Uncertainty Theories 
Uncertainty in Illness Theory 
The findings of this dissertation have implications for three theories related to 
health and illness uncertainty.  First, Mishel’s (1988, 1990) theory of uncertainty in 
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illness helps explain this dissertation’s findings.  This theory argues patients facing long-
term health illnesses must learn how to manage chronic uncertainty.  According to the 
theory, a previvor is uncertain when she cannot form cognitive representations of her 
high cancer risk.  This lack of cognitive capacity is caused by previvors’ uncertainty 
sources such as lack of information about the unknown future, lack of awareness about 
cancer risk, lack of experience with possible cancer scares, and a lack of understanding 
in how to manage the uncertainties (Mishel, 1988; Mishel & Braden, 1988).  
In other words, previvors experience chronic uncertainty about developing breast 
and ovarian cancer because there is always a threat.  As the findings indicate, a previvor 
might undergo BRCA genetic testing to reduce her uncertainty about whether or not she 
has a high cancer risk, but if she tests positive for the BRCA1/2 gene, new uncertainties 
arise.  She now must deal with uncertainties like visiting clinicians every six months, 
waiting for test results at least twice a year, reliving loved ones’ traumatic battles with 
cancer, and/or worrying about whether she will be around to watch her children grow up.   
Further, in Mishel’s terms, previvors tend to appraise uncertainty as a threat and 
thus often adopt uncertainty reduction strategies.  To reduce uncertainty, structure 
providers like educational level, social support, and credible authority can be employed 
(Mishel, 1988); however, social support and credible authority are most relevant for 
previvors’ experiences.   
First, the uncertainty management strategy of seeking referrals from clinicians 
for emotional support is supported by this theory as a support network helps prevent life 
crises by providing information on what illness events mean.  More specifically, social 
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support opens opportunities for communication between individuals with similar 
experiences as well as reveals how such individuals handle threatening illness events 
(Mishel, 1988).  Thus, the ability to communicate about one’s high cancer risk through 
open discussion in supportive networks aid previvors in forming cognitive schema about 
illnesses (Wortman, 1984).   
Also, the uncertainty management strategy of seeking clinicians as an 
informational source reflects Mishel’s (1988) credible authority component.  Credible 
authority refers to previvors’ trust and confidence in their clinicians.  Having and 
interacting with credible clinicians strengthens stimuli frame by providing information 
about physical symptoms to look for, environmental situations to be aware of, and 
discrepancies between expectations and possible experiences and outcomes.  Hence, 
credible authority is important because the clinician-patient relationship is a vital means 
to prevent uncertainty (Mishel & Braden, 1988; Mishel et al., 2005). In brief, Mishel’s 
theory of uncertainty in illness assists in explaining why previvors see uncertainty as a 
threat and thus implement coping strategies.  
Uncertainty Management Theory 
Second, because previvors’ uncertainty cannot always be reduced, this study has 
important implications for uncertainty management theory (Brashers, 2001).  
Uncertainty management theory is “a theory of the process of communication and 
uncertainty management in which the desire to reduce uncertainty is assumed to be only 
one of several possible responses to events and circumstances marked by 
  104 
unpredictability, ambiguity, or insufficient information” (Brashers et al., 2000, p. 64, 
emphasis in original).   
For one, the findings reveal previvors’ uncertainty sources are intrinsically 
connected, and when attempting to manage such sources through particular strategies, 
sometimes the uncertainties can be reduced, while others may be heightened.  For 
example, previvors’ medical uncertainty sources (e.g., the unknown future, peaks and 
valleys, and personal cancer scares) are related to each other.  Leading up to a medical 
consultation, a previvor begins to experience anxiety about what the clinician may find 
in her breasts or ovaries.  Then during a mammogram or ultrasound, a clinician might 
find something suspicious, and she must wait for test results.  Both of these sources of 
medical uncertainty only reinforce previvors’ fears about the unknown future.  This 
connection supports uncertainty management theory’s key principle that uncertainty 
cannot always be eliminated and thus must be managed (Brashers et al., 2001).   
Along this line, the findings support information seeking and information 
avoidance as types of uncertainty management strategies.  According to Brashers et al. 
(2003), information seeking can assist in reducing uncertainty, while information 
avoidance helps evade distressing or overwhelming information.  Information seeking 
has been found to be an important way to manage uncertainty (Pomerantz, 1988). 
Previvors heavily emphasized the importance of seeking clinicians as an informational 
source in order to manage their medical and familial uncertainties. By interacting with 
clinicians who are knowledgeable about BRCA, provide information, answer questions, 
check understanding, and provide additional resources, previvors’ uncertainties are 
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reduced and managed because information distinguishes options and fosters meaning 
(Brashers, 2001; Brashers et al., 2000).  
It is important to note though that while the majority of previvors expressed 
seeking clinicians as an information source as a way to manage their uncertainties, a few 
participants did not.  It might be argued previvors who did not choose preventative 
surgeries as a way to manage their high cancer risk and instead opted for increased 
surveillance are avoiding information and thus maintaining their uncertainties.  More 
research needs to explore this possibility.  
Finally, the findings of this dissertation also validate this theory’s emphasis on 
social support as an uncertainty management strategy.  Previvors’ uncertainty 
management strategy of seeking referrals from clinicians for emotional support again 
stresses the importance of having a social support system.  As stated previously, 
inadequately managed uncertainty produces harmful psychosocial effects (Neville, 
1998), but social support improves individuals’ psychological and physical health 
(Brashers, 2001).  For previvors, supportive others assist in the uncertainty management 
process because they provide a relationship with someone who understands their 
experience, serves as an information source for coping and making health decisions, 
offers opportunities for venting, and validates each other’s negative emotions and 
feelings (Brashers, 2001).  In sum, Brasher’s uncertainty management theory helps 
explain previvors’ uncertainty sources and uncertainty management strategies.   
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Problematic Integration Theory 
Third, the dissertation’s findings speak to problematic integration theory (PI).  PI 
theory seeks to address an individual’s expectations, desires, and uncertainty 
management (Ford, Babrow, & Stohl, 1996).  PI theory acknowledges individuals assess 
life based on probabilities through two ways—an individual’s ideas regarding the 
likelihood an event or issue will happen during her lifetime (termed probabilistic 
orientations) and the individual’s ideas about the goodness or badness or the desirability 
or undesirability of an event or issue (termed evaluative orientations; Babrow, 1995; 
Babrow, 2001; Sparks & Villagran, 2010).   
PI theory helps explain previvors’ experiences with uncertainty.  According to 
the theory, uncertainty arises when previvors’ judgments about the likelihood of the 
unwanted outcome (read: not developing cancer) and the desired outcome (read: health 
decisions preventing cancer) conflict (Babrow, 2001; Sparks & Villagran, 2010).  For 
example, all previvors do not want cancer, but they are often uncertain about what 
preventative health decision to make (e.g., increased detection, chemoprevention, or 
prophylactic surgeries).  This uncertainty may exist because, on one level, the previvor is 
overwhelmed with the information provided for each health option; while at the same 
time, she may be uncertain about whether the chosen option will reduce her cancer risk.  
Consequently, problematic integration occurs when the expectations previvors hold and 
the evaluations previvors think will occur are at odds.   
PI theory also helps explain situations where probabilistic and evaluative 
orientations are in conflict, or problematic, and explicates previvors’ uncertain 
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experiences.  PI tries to sheds light on what individuals “ought to believe and whether 
what they believe is good or bad” (Matthias & Babrow, 2007, p. 788).  Moreover, 
probabilistic orientations are rooted in cognition, while evaluative orientations are rooted 
in emotions, and though these two orientations are interdependent, sometimes one 
orientation receives more attention (Babrow, 1995, 2001; Bradac, 2001).   
Using Babrow’s terms, for many previvors, their probabilistic orientation tells 
them they will get cancer during their lifetime because of their high genetic risk, while 
their evaluative orientation tells them engaging in certain health decisions such as 
increased detection, chemoprevention, or preventative surgeries may reduce their risk.  
In other words, though previvors are aware of their cancer probability and all the 
possible health options, previvors’ medical and familial uncertainties and the intense 
desire to never get cancer profoundly influences their health decisions (read: undergoing 
preventative surgeries)—thus emphasizing evaluative orientations over probabilistic 
ones.   
Lastly, a crucial component of PI theory is that communication is essential to 
problematic dilemmas because it serves as a “source, medium, and resource” (Babrow, 
1995, p. 286), meaning PI is constructed, maintained, and altered through 
communication (Babrow, 1992, 2001, 2007).  For instance, communication serves as a 
coping mechanism for individuals experiencing PI (Matthias & Babrow, 2007).  
Previvors engage in communication with their clinicians as a way to manage their 
uncertainty and make health decisions in clinical encounters.  Whether they seek 
clinicians as an informational, decision-making, or emotional source, communication 
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between previvors and clinicians assists in addressing expectations and desires as well as 
the management of uncertainty (Ford, Babrow, & Stohl, 1996).  Overall, communication 
enables a previvor “to reappraise the value she or he places on a particular event or 
object” (Matthias & Babrow, 2007, p. 789).   
Practical Implications 
In addition to theoretical implications, several practical implications can be 
derived from this study.  Based on the findings of this dissertation, I now discuss 
important take-away points for managing chronic uncertainty and patient-clinician 
communication.  
Managing Chronic Uncertainty 
First and foremost, this dissertation’s findings stress the complex nature of 
managing chronic uncertainty.  Uncertainty becomes chronic when an individual must 
constantly and consistently manage inconsistency, ambiguity, and unpredictability about 
health and illness over a long period of time (Brashers, 2001).  Though previvors do 
experience uncertainty in clinical encounters, which leads them to make particular health 
decisions, sometimes, even after undergoing the most extreme and risk-reducing 
preventative surgeries, previvors are still uncertain.  Said differently, a preventative 
surgery may be seen as the best way to reduce uncertainty, but there is always a small 
chance of developing cancer, and thus uncertainty must be managed continually.  So it is 
simply not enough for clinicians to help previvors when they are determining to undergo 
genetic testing. It is not enough for clinicians to assist previvors after they make their 
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preventative health decision.  It has to be a continued conversation. Clinicians need to 
help their previvors manage their uncertainty throughout their health journey.   
Moreover, though this dissertation focused on managing uncertainty within the 
clinical encounter, previvors’ uncertainty sources in clinical encounters may reveal a 
need to explore and manage uncertainties outside medical consultations.  One way to 
help previvors manage their chronic uncertainty is by teaching previvors self-
management skills for when they leave clinical consultations (Epstein & Street, 2007).  
For instance, clinicians can teach previvors how to create action plans and lay out 
contingencies if cancer is discovered at some point.  Additionally, clinicians should 
discuss the benefits of journaling, meditation, positive thinking, and calming self-talk as 
well as teach such skills to help manage uncertainty (Mishel et al., 2005; Fatter & Hayes, 
2013; Ullrich & Lutgendorf, 2002; Utley & Garza, 2011; Wagner et al., 2001).  That 
way, when previvors leave the clinical encounter, the uncertainty “does not swallow 
[them] whole like a black hole.”  
Recommendations for Clinician-patient Communication 
Given the above point about chronic uncertainty, the dissertation also 
necessitates vital recommendations for patient-clinician communication.  When asked 
about recommendations for improving communication between patients and clinicians, 
previvors advocated for the following five recommendations: (1) be knowledgeable 
about BRCA; (2) provide more information; (3) encourage previvors to be active 
patients; (4) use patient advocates; and (5) stress being a part of social support system.  
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First, paralleling the uncertainty management strategy of seeking clinicians as an 
informational source, previvors need clinicians who are knowledgeable about BRCA 
related issues.  Previvors state genetic counselors, gynecologists, breast surgeons, plastic 
surgeons, and oncologists need to be experts in BRCA.  In fact, previvors’ medical and 
familial uncertainties are often increased when their clinicians do not know what they 
are talking about and thus previvors cannot trust their clinicians to provide accurate and 
up-to-date information about risk and prevention.  Though it is a good start if clinicians 
are familiar with cancer patients and survivors, previvors’ experiences are different and 
need to be respected.  
Second, related to the same uncertainty management strategy, previvors 
emphasized the desire to receive more information from their clinicians.  Previvors view 
information as empowering.  Information and statistics about cancer risk, details about 
available health options for preventing cancer, and side effects, risks, and benefits for the 
different health decisions help previvors manage their uncertainties and feel in control of 
their lives.  Also, information on social support groups is important because previvors 
feel like their clinicians care about their well-being.  
Third, because clinicians are often not knowledgeable about BRCA or do not 
provide enough information, previvors need to actively participate in their own care.  
Previvors suggest clinicians should encourage and support patient participation.  
Actively participating means being knowledgeable, understanding one’s body, doing 
research, asking good questions, and being honest and direct with clinicians about 
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preferences. Because in the end, as a Maria (30-year old, Caucasian BRCA2) stated, 
“You are your own best advocate.” 
Fourth, previvors promoted the use of patient advocates in the BRCA medical 
community.  According to the National Patient Safety Foundation, a patient advocate is 
“a supporter, believer, sponsor, promoter, campaigner, backer, or spokesperson” who 
acts on the patient’s behalf (p. 1).  Patient advocates would be helpful because previvors 
are not cancer patients or survivors, and so clinicians often do not know how to treat 
previvors.  Hence, a BRCA patient advocate could focus on educating previvors on self-
management as well as determining what care is needed based on their preferences.   
Finally, mirroring the uncertainty management strategy of seeking clinicians for 
emotional support referrals, previvors stress the importance of being a part of social 
support system.  Whether such support comes from previvors’ families, friends, or 
online communities, having a support system is essential for attempting to manage 
chronic uncertainty (McCormack et al., 2011).  So in clinical encounters, clinicians 
should check and make sure previvors have a network, and if they do not, then clinicians 
should provide a list of former previvor patients who are willing to talk about their 
experiences.  This way no previvors ever feels alone in the journey through hereditary 
cancer.  
In sum, clinicians need to engage in patient-centered communication in order to 
help previvors manage their health journey.  Clinicians must engage in effective 
information exchange, foster healing relationships, respond appropriately and effectively 
to emotions, assist in making quality decisions, enable patient self-management, and 
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manage uncertainty (Epstein & Street, 2007).  Doing so will assist previvors in 
managing their medical and familial uncertainties and make the best health decisions for 
their lives.  
Conclusions  
Limitations 
There are two main limitations of the present study. The first limitation is the 
sample.  The study’s population was not very diverse.  The lack of diversity was partly 
due to sampling.  Because I wanted to interview female previvors who strongly 
identified as a previvor (or a BRCA+ individual), I targeted particular groups.  
Furthermore, because I used online methods (e.g., social media pages) to recruit my 
participants, it is likely I am missing parts of the previvor population.  For example, the 
digital divide might play into the lack of diverse participants, yet at the same time, more 
individuals now have access to the Internet (Hong, 2008) and are using the Internet for 
social support (Wald, Dube, & Anthony, 2007).   
Additionally, the majority of the participants were Caucasian and between the 
ages of 30 and 40 years old.  However, these demographics might also be explained by 
cancer recommendations.  For example, it is recommended previvors consider removing 
their ovaries and uterus between ages 35 and 40 as well as to consider undergoing a 
preventative double mastectomy around age 35 (Friedman, Sutphen, & Steligo, 2012).  
Thus, it is possible such demographic factors skewed the decisions the previvors made 
and shared.   
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Second, the findings are limited to previvors’ uncertainty experiences.  Because 
managing uncertainty is a communicative process especially within clinical encounters 
(Epstein & Street, 2007), clinicians’ perspectives of previvors’ sources and strategies for 
managing uncertainty are missing.  Therefore, future research should explore how 
clinicians, who interact with previvors, help manage previvors’ uncertainties.  Exploring 
such perspectives will hopefully shed light on how clinicians can further assist previvors 
in managing their uncertainties.  
Future Research 
Although the present study’s findings speak to uncertainty in cancer care, 
additional exploration is warranted.  Generally, future research should test how clinician-
patient communication about uncertainty sources and uncertainty management strategies 
impact health outcomes.  Hypotheses could test how the patient-centered communication 
function managing uncertainty leads to intermediate and long-term health outcomes 
(Epstein & Street, 2007; Street et al., 2009).  By testing proposed pathway models based 
on qualitative research like the current dissertation, scholars can further understand how 
communication impacts health outcomes.  Also, because previvors experience chronic 
uncertainty, previvor-focused uncertainty management interventions should also be 
developed and tested.  Finally, clinicians especially gynecologists, oncologists, and 
breast and plastic surgeons, need to be trained to frame and provide information to 
previvors in ways that manage anxiety and achieve understanding; clinicians also need 
to learn how to offer quality emotional support and know how to provide a referral to 
appropriate specialists.   
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Summary 
This dissertation explores sources of uncertainty and strategies for uncertainty 
management in cancer care yet extends such understandings to a new population—
previvors. Data were collected through semi-structured interviews. Previvors’ sources of 
uncertainty, uncertainty management strategies, and health decisions are identified in the 
interview transcriptions.  Analysis revealed medical and familial uncertainty, four 
uncertainty management strategies—seeking clinicians as an informational source, 
seeking clinicians as a partner for decision-making, seeking clinicians as an emotional 
support, and seeking referrals from clinicians for emotional support—and found 
previvors’ uncertainty sources and uncertainty management strategies impact their 
preventative health decisions.  
Overall, the purpose of this research is to gain insight into previvors’ uncertain 
health experiences in order to improve patient-centered communication between 
previvors and clinicians and ultimately previvors’ health and well-being.  This research 
contributes to the literature by extending the exploration of uncertainty management to a 
new population, reinforcing the belief that chronic uncertainty should be managed not 
reduced, supporting health and illness uncertainty theories, and providing practical 
recommendations for clinician-patient communication.   
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APPENDIX A
INTERVIEW GUIDE 
Demographic Questions 
1. Do you identify as male or female? 
2. What is your age? 
3. What race/ethnicity do you identify as? 
4. Have you tested positive for either BRCA1 or BRCA2 gene mutation?  
5. How long have you know your genetic test results? 
 
Interview Questions 
1. Opening Question: How do you feel about your family’s cancer history? What 
emotions do you experience? 
2. What do you believe your risk or likelihood is for developing breast or ovarian 
cancer in your lifetime? 
3. How did you learn about your high genetic risk? Where do you get your 
information about the BRCA mutation and its associated health risks? 
4. What causes you to be uncertain or anxious about your future risk for breast or 
ovarian cancer?  
5. How do you cope with the possibility of developing cancer in the future? Can 
you give me a specific example of how you use that strategy to cope? 
6. What is the clinician’s role in helping you manage your uncertainty (and anxiety) 
about the possibility of developing cancer in the future and ultimately make 
health decisions? 
7. Do your encounters with clinicians increase or decrease your uncertainty (or 
anxiety) about your future risk? How so? Can you give me an example of when 
your uncertainty was increased or decreased after talking to a clinician about 
your genetic risk? 
8. *Tell me what it means to you to be a “previvor.” (Only ask this question once 
the interview participant mentions this term). 
9. Closing Question: Is there anything else you would like to tell me? Perhaps 
something I did not address that you think is really important given our 
conversation and your experiences? 
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APPENDIX??
 LIST OF PARTICIPANTS’ DEMOGRAPHICS 
Name Race/Ethnicity Age BRCA Gene  Health Decision 
Savannah Caucasian 31 BRCA1 Preventative mastectomy, 
oopherectomy, and 
hysterectomy 
Mary Caucasian 30 BRCA2 Preventative mastectomy 
Elizabeth Caucasian 32  BRCA1 Increased surveillance and 
then preventative mastectomy 
Carly Caucasian and 
Ashkenazi 
Jewish 
31 BRCA1 Increased surveillance and 
then prophylactic mastectomy 
Jenelle Caucasian and 
Ashkenazi 
Jewish 
41  BRCA1 Preventative oopherectomy 
and plans on getting 
mastectomy 
Madison Caucasian 32  BRCA1 Preventative mastectomy 
Janet Caucasian 51 BRCA1 Increased surveillance and 
then prophylactic mastectomy 
Jacklynn Caucasian and 
Colombian 
34 BRCA1 Preventative mastectomy and 
oopherectomy 
Madeline Caucasian 38 BRCA2 Preventative mastectomy 
Kelly Caucasian 44 BRCA1 Preventative oopherectomy 
but scheduled mastectomy 
Sarah Ashkenazi 
Jewish 
56 BRCA1 Preventative oopherectomy 
and mastectomy 
Jamie Caucasian 27 BRCA2 Increased surveillance and 
then prophylactic mastectomy 
Camille Caucasian and 
Ashkenazi 
Jewish 
47 BRCA2 Increased surveillance and 
then prophylactic mastectomy 
Nancy Caucasian 40 BRCA2 Preventative oopherectomy 
and hysterectomy and then 
preventative mastectomy 
Lacy Caucasian 51 BRCA2 Preventative oopherectomy 
and hysterectomy, 
chemoprevention, and 
increased surveillance 
Tara Caucasian 28  BRCA2 Preventative mastectomy 
Anna Caucasian and 
Ashkenazi 
Jewish 
44 BRCA1 Preventative mastectomy and 
hysterectomy 
Sue Caucasian 60 BRCA1 Preventative mastectomy and 
then hysterectomy 
  138 
Jennifer Caucasian 30 BRCA2 Preventative mastectomy 
Jasmine Caucasian 32 BRCA2 Increased surveillance 
Samantha Caucasian 35 BRCA2 Preventative mastectomy and 
then oopherectomy 
Rebecca Caucasian 44 BRCA2 Preventative mastectomy and 
then oopherectomy 
Theresa Caucasian 34 BRCA2 Increased surveillance and 
planning mastectomy soon 
Maria Caucasian 30 BRCA2 Increased surveillance and 
then preventative mastectomy  
Bailey Caucasian 33 BRCA1 Increased surveillance and 
then preventative mastectomy  
Veronica Caucasian 38 BRCA2 Preventative mastectomy 
Shauna Caucasian 67 BRCA2 Preventative mastectomy and 
then hysterectomy 
Skylar Caucasian and 
Hispanic 
30 BRCA1 Preventative mastectomy 
Sophia Chinese 33 BRCA2 Preventative mastectomy 
Caitlyn Caucasian 37 BRCA2 Preventative hysterectomy 
and considering mastectomy 
Addison Caucasian 33 BRCA1 Preventative mastectomy 
Tiffany Caucasian 38 BRCA1 Preventative mastectomy and 
then oopherectomy 
Alexa Caucasian 38 BRCA1 Increased surveillance 
Gabriella Caucasian 39 BRCA1 Preventative mastectomy and 
considering oopherectomy 
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APPENDIX??
LIST OF TECHNICAL TERMS 
• Preventative mastectomy = The surgical removal of one’s breasts in order to 
prevent breast cancer.  
• Preventative oopherectomy = The surgical removal of one’s ovaries in order to 
prevent ovarian cancer.  
• Preventative hysterectomy = The surgical removal of one’s uterus in order to 
prevent ovarian cancer.  
